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Abstract 
The La protein, also referred to as Sjogren’s Syndrome antigen B (SSB), is an RNA-
binding phosphoprotein first identified as an auto-antigen in patients suffering from Sjogren’s 
syndrome and systemic lupus erythematosus. La proteins are present and indispensable in nearly 
all eukaryotes and exhibit conserved functions in RNA metabolism. By shuttling between the 
nucleus and cytoplasm, La interacts with RNA substrates transcribed by both RNA Polymerase III 
and RNA polymerase II. For human La (hLa), hLa phosphorylated at S366 is typically found in 
the nucleus and involved in facilitating the processing and maturation of RNA polymerase III 
transcripts by binding to the UUU-3'OH trailer in a sequence specific manner. In addition to 
assisting in the processing of nascent RNA polymerase III transcripts, La proteins are associated 
with promoting cap-independent translation from the internal ribosome entry sites (IRESs) of 
several cellular and viral coding RNAs. However, the mechanism of La binding to coding RNAs 
is poorly understood. In this study, we investigated the molecular mechanisms by which La 
interacts with coding transcripts. In Chapter 2, we show that in addition to a sequence specific 
UUU-3'OH binding mode, human La (hLa) exhibits both a sequence specific and length dependent 
poly(A) binding mode mapped to the canonical winged helix face of the eponymous La motif.  
Moreover, we also demonstrate that cytoplasmic La engages poly(A) RNA in human cells, La 
entry into polysomes utilizes the poly(A) binding mode, and La promotion of translation from the 
cyclin D1 IRES occurs in competition with the cytoplasmic poly(A) binding protein (PABP).  
During viral infection, tumor progression, and certain forms of cellular stress, the 
predominantly nuclear hLa protein has been shown to translocate to the cytoplasm where it 
functions as an IRES trans-acting factor (ITAF), controlling cap-independent translation initiation 
of several cellular IRES-containing mRNAs involved in stress responses, signifying an important 
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role for hLa during stress.  In Chapter 3, we aim to understand the cellular conditions during which 
La interacts with its cytoplasmic substrates and identify novel RNA substrates of La. We show 
that cellular stress induced by clotrimazole, an inducer of stress granules and mitochondrial stress, 
results in translocation of hLa from the nucleus to the cytoplasm. Using polysome analysis and 
qPCR, we also show that La translocation into cytoplasm is concurrent with increased association 
of La with actively translating messages, especially messages containing IRESs. Using individual 
crosslinking immunoprecipitation (iCLIP) analysis, we identify novel hLa associated targets. 
Taken together, these results suggest that hLa is trafficked into the cytoplasm in response to 
cellular stress in order to associate with IRES containing messages, and this interaction may occur 
through contacts made via a novel binding mode with the poly(A) tail.   
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Review of Literature 
  
 2 
1.1 Eukaryotic Gene Regulation 
 
1.1.1 Post-transcriptional Gene Regulation 
 
DNA is a repository of genetic information and acts as a blueprint that is passed from 
generation to generation 1(p30). DNA is transcribed into RNA, and RNA is translated into protein. 
Although it was once widely believed that only DNA and protein were important to the central 
dogma, while RNA was simply an intermediate accessory, in the past 30 years, extensive research 
has shed light on the equally important role of RNA in expressing genetic information 1(p37). The 
“RNA World Hypothesis” proposes that RNA was the precursor to all currently existing life, since 
it has a functional versatility unlike that of DNA or protein 2. To translate DNA-encoded 
information into protein and accurately express genes, a plethora of intricate mechanisms have to 
occur precisely. 
Gene expression begins in the nucleus, where DNA binding proteins bind to DNA 
sequence elements and recruit RNA polymerases (RNA Pol) for RNA synthesis 3. Precursor 
messenger RNAs (pre-mRNAs) are single-stranded mRNAs synthesized from a DNA template 
which undergo various post-transcriptional modifications including 5' capping, 3' polyadenylation, 
and splicing 4–7. Once exported through nuclear pores into the cytoplasm, mature RNA transcripts 
are transported to predestined subcellular regions for translation and storage 8,9 (Figure 1). 
Translation factors and ribosomes are then recruited to mRNAs to initiate translation and produce 
protein. Eventually, mRNAs are degraded by exonucleases 10.  
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Figure 1: Schematic of the eukaryotic gene expression 
During transcription, DNA is converted to make nascent mRNA precursors in the nucleus. mRNAs 
undergo a series of modifications including splicing, capping, and polyadenylation before 
becoming mature transcripts. mRNAs are then exported through nuclear pores into the cytoplasm, 
where they are destined to numerous subcellular regions. The transcripts, along with translation 
factors and ribosomes, make proteins. Finally, mRNAs undergo exonuclease-mediated 
degradation through various decay pathways. Figure adapted from 3. 
 
The recent development of new genomic and proteomic tools has led to significant progress 
in the field of post-transcriptional regulation. Although DNA binding proteins are the key 
regulators of transcription, many post-transcriptional processes are also regulated by RNA-protein 
and RNA-RNA interactions. These ribonucleoprotein complexes (RNPs) are essential for the 
control of various aspects of gene regulation including capping, splicing, A-tailing, export, and 
transport 6,11. More than 500 proteins are predicted to function as RNA binding proteins (RBPs) in 
budding yeast Saccharomyces cerevisiae, and it is predicted that RBPs comprise 3 to 11% of 
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proteomes in bacteria, archaea, and eukaryotes 12–14. Through proteomic screens and other RNA 
binding assays, the continuous discovery of novel RBPs further confirms the significance of this 
protein family in the regulation of gene expression. 
1.1.2 RNA Binding Proteins 
 
From the moment it is transcribed, an RNA molecule is never alone, as RBPs bind nascent 
RNA targets to drive forth both transcription and translation, thus playing a significant role in 
various aspects of gene expression 7. For example, in humans, capping enzymes add a 7-
methylguanylate (m7G) cap to nuclear pre-mRNA to prevent degradation 15. Once exported to the 
cytoplasm, several eukaryotic initiation factors (eIFs) bind the 5' cap to stabilize the mature mRNA 
and recruit ribosomes to initiate eukaryotic translation.  Similarly, polynucleotide 
adenylyltransferase (PAP) is an enzyme that adds adenine residues at the 3'OH end of newly 
synthesized pre-mRNAs in the nucleus 16. The nuclear Poly(A) Binding Protein (PABP-N1/ PABP 
II) binds the nascent, developing poly(A) tail to protect against degradation and assists in the export 
of mRNA from the nucleus to the cytoplasm 17,18. Once in the cytoplasm, the mature mRNA 
transcript is bound by PABP-C1, which helps to stabilize the mRNA during translation. Hence, 
both nuclear and cytosolic PABP are necessary to prevent mRNA degradation at various stages. 
RBPs also assist in the processing and assembly of non-coding RNAs (ncRNAs) into RNP 
complexes, mediating both splicing and translation 19. All of these steps are essential and 
interdependent to ensure proper gene expression 5. Several studies using different eukaryotic 
systems have demonstrated the importance of functional RBPs to regulate post-transcriptional 
modifications and the process of translation 6,20,21.  
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The ease and accessibility of new genomic tools allows for greater screening of large data 
sets to detect RBPs and their targets. Currently, the two most popular and widely used techniques 
include RNA immunoprecipitation coupled with sequencing (RIP-seq) and cross-linking 
immunoprecipitation (CLIP). RIP-seq involves the immunoprecipitation of RNP complexes, 
followed by the analysis of the associated RNAs using next generation sequencing. RIP-seq detects 
stronger and more stable RNA-RBP interactions. Unlike RIP-seq, CLIP employs ultraviolet (UV) 
crosslinking of RNA to proteins prior to immunoprecipitation of the associated RNAs (Figure 2). 
Irradiation of cells at 254 nm creates covalent bonds between nucleotides and photo-reactive amino 
acids that reside in close proximity. Hence, high efficiency crosslinking is crucial for this approach, 
and this additional crosslinking step alleviates any potential background signals compared to the 
RIP-seq technique 22,23. The crosslinking step also allows for the identification of less stable, 
transient RNA-RBP interactions. After partial RNAse digestion and reverse transcription to make 
cDNA, the cDNA is amplified using PCR and then prepared for next-generation sequencing. RNA-
protein sites can then be identified by mapping reads and aligning them to the appropriate 
transcriptome. This method was first used to identify RNA targets of the neuron specific splicing 
factor NOVA1 and NOVA2 in mouse brain 23,24. Various modifications of the CLIP protocol have 
been used successfully to identify the RNA targets of proteins such as Argonaute, heterogeneous 
nuclear ribonucleoprotein C (hnRNP C),  polypyrimidine tract-binding protein (PTB), and the 
Fragile-X mental retardation protein (FMRP) 25–28. 
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Figure 2: Schematic of CLIP methods 
CLIP protocols rely on the use of UV crosslinking RNA with proteins. In PAR-CLIP, cells are 
cultured in 4-thiouridine containing medium resulting in 4SU-labelled transcripts. In HITS-CLIP 
and iCLIP, cells are cultured in regular medium and UV crosslinked to RBPs.  Partial RNase-
digestion of lysates leaves behind portions of RNA directly bound by protein. Radioactively 
labelled RNA-protein complexes are recovered by immunopurification and size-fractionation. 
Proteins are degraded via proteinase K treatment to release RNA molecules. RNAs are then 
converted into a cDNA library and deep sequenced. Figure taken from29.  
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1.1.3 Common Features of RNA Binding Proteins 
RNA interactions mediated by RBPs can be target specific. Bioinformatics analysis on 
several RBPs suggests that these proteins contain RNA binding domains that have been highly 
conserved through eukaryotic evolution 30. RBPs are often composed of modular structures 
containing multiple repeats of a few basic domains.  Using nuclear magnetic resonance (NMR) 
with protein-RNA complexes and co-crystal structures of RBPs bound to RNAs, it has been shown 
that distinct, conserved residues interact with bases and backbones of their RNA substrates 31–33. 
These non-covalent intermolecular interactions are generally hydrogen bonding or stacking 
interactions, mediated by Van der Waals forces between aromatic residues and the purine or 
pyrimidine rings of RNA 34. Cooperation between the different modules contribute to the ability 
of the protein to bind different substrates and to the multifaceted functions of the protein (Figure 
3). Modules can also cooperate with enzymatic domains to regulate the activity of catalytic 
enzymes that associate with RNA.  
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Figure 3: RNA-binding proteins bind RNA using different binding modes 
RNA-binding proteins can recognize substrates in a sequence specific, structure specific, or a non-
sequence specific manner.  (A) Multiple domains cooperate with each other to recognize short or 
long RNA sequences. Longer sequences, or sequences within RNA that are separated by many 
nucleotides may require more than one domain for recognition. One RBP may also bind more than 
one RNA at a time. (B) RNA binding domains bind RNA in a structure-specific manner as opposed 
to a sequence-specific manner. (C) Domains of an RBP may interact with each other while also 
interacting with RNA.  Figure adapted and modified from 35. 
 
A well-studied example of a RBP consisting of multiple domains that, in concert, facilitate 
interactions with RNA and other proteins is the cytosolic poly(A) binding protein (PABP-C1). 
Poly(A) binding protein binds adenosine residues at the 3'OH end of mRNA and assists in mRNA 
stability and translation. PABP-C1 is comprised of four non-identical RNA recognition motifs 
(RRMs) followed by a proline-rich region and carboxyl terminal domain, referred to as PABC 36. 
While adenine recognition is mediated by conserved residues within the two N-terminal RRMs, 
the PABC domain is responsible for recognizing a conserved 15-residue sequence, part of the 
PABP interaction motif (PAM-2) 37. The PAM-2 motif is found on several proteins that bind to 
PABP including PABP interacting proteins 1 and 2 (PAIP 1, PAIP 2) and the La-related protein 4 
(LARP4) 38,39. Similarly, the La protein which consists of a La motif and two RRMs, uses a 
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combination of modules to bind distinct substrates. While the La motif and the N-terminal RRM 
are involved in binding to RNA polymerase III transcribed substrates of La, the La motif, along 
with both the N- and C-terminal RRM, are involved in binding a viral substrate of La, the internal 
ribosome entry site (IRES) of the Hepatitis C Virus 40,41.  
In addition to RNA binding domains, the length and flexibility of linker regions inbetween 
modules allows the RBP to bend, facilitating a greater number of interactions with different 
substrates. The arrangement and cooperation between these modules are instrumental for the 
diverse RBP functionality. For instance, in the La protein, the linker that bridges the La motif and 
N-terminal RRM in its RNA-free form is long and flexible. However, the corresponding linker 
found within La-related proteins families 4 and 6 (LARP4 and LARP6) appear to be shorter and 
more rigid 42. It is hypothesized that the difference in linker flexibility and length may account for 
the ability of La to function in facilitating the processing of both RNA Pol III and RNA Pol II 
transcripts, while La-related protein families targeting are restricted to only one of these classes 
(further discussed in section 1.5).  
Greater conservation of RNA binding domains is found in proteins that are orthologous, 
meaning they are direct evolutionary counterparts, performing similar functions in different 
organisms.  For example, there are more similarities between the RRM1 of yeast PABP and human 
PABP, than between the RRM1, RRM2, and RRM3 of yeast PABP 43. There are numerous 
examples of highly conserved RNA binding domains between different protein families including: 
the La-motif (LAM), RNA recognition motif (RRM), the SAM (Sterile alpha motif) domain, the 
K-homology (KH) domain, zinc-fingers (ZnFs), the double stranded RNA-binding domain 
(dsRBD), the Pumilio domain, and the Piwi/Argonaute/Zwille (PAZ) domain (Table 1) 35.  RRM, 
also known as the RNA binding domain, is comprised of ~80 amino acids and is the most common 
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motif found in RNA binding proteins. NMR and X-ray crystallography have confirmed that the 
structure of RRMs consists of a four-stranded anti-parallel β-sheet with two helices packed against 
it, so that the domain presents a split αβ (βαββαβ) topology 44. Studies of several RRM-containing 
RBPs have shown that RNA recognition usually occurs on the surface of the β-sheet, where 
binding is mediated by three conserved residues: either an arginine or lysine residue, which forms 
a salt bridge to the phosphodiester backbone, along with two aromatic residues that facilitate 
stacking interactions with nucleobases 35. 
 
Table 1: Common RNA-binding domains and their properties 
 
Table was adapted and modified from 35.  
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1.2 La Proteins 
1.2.1 Overview of La Proteins 
 
First discovered in 1974, La is an RNA-binding phosphoprotein identified as an auto-
antigen in patients suffering from Sjogren’s syndrome, neonatal lupus, and systemic lupus 
erythematosus 45,46. Using La antibodies, levels of circulating La were measured to diagnose 
patients as having systemic lupus erythematosus and neonatal lupus syndrome 47,48. Although it is 
still unclear why La is targeted as an autoantigen, several decades of research have shed light on 
the multifaceted functions of this protein which has helped to further our understanding of RNA-
RBP interactions. Abundantly found at approximately 20 million copies per cell, La proteins were 
one of the first RBPs to be identified, and thus have pioneered RBP research. La is ubiquitous 
across eukaryotes and its function in RNA metabolism is highly conserved. While La is an essential 
gene in all metazoans investigated to date including Trypanosoma, Arabidopsis thaliana, 
Drosophila Melanogaster, and mice, it is dispensable in both budding and fission yeast, making 
yeast a good model system for genetic studies 49,50. 
La shuttles between the nucleus and the cytoplasm interacting with various RNA substrates 
51,52. In humans, hLa (human La) is phosphorylated at serine-366 (S366) and is typically found in 
the nucleus. La is involved in facilitating the processing of RNA polymerase III transcripts such 
as U6 snRNA, tRNA precursors, and pre-5S rRNA by protecting the transcript from 3'-5' 
exonuclease degradation by exonucleases such as Rex1p 53,54. Transcription termination by RNA 
Pol III produces a 3′ oligo(U) trailer, which serves as a high affinity binding site for La. Affinity 
towards this RNA Pol III substrate is dependent on the length of the oligo (U) tract 54,55. While the 
interaction of La with substrates that end with the UUU 3'OH trailer have been well characterized, 
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its interaction with substrates that lack this trailer is still under investigation. Non-phosphorylated 
hLa is found in the cytoplasm, where it binds and enhances the expression and translation of 
cellular and viral mRNAs through the use of internal ribosome entry sites (IRES), 5' terminal 
oligiopyrimidine tracts (5' TOPs), and upstream open-reading frames (uORFs). This interaction 
has been identified in various cellular IRESs including the binding immunoglobulin protein (BiP) 
and Cyclin D1 (CCDN1) and in several viral IRESs including Hepatitis C, encephalomyocarditis 
virus, and poliovirus 41,56–58. The mechanism by which La binds to the IRES to enhance translation 
is still under investigation.  La binding to non-Pol III transcripts is less well characterized in yeast, 
although S. cerevisiae La (Lhp1p) has been shown to engage mRNAs, in addition to the expected 
RNA Pol III substrates 59.  
 
1.2.2 Structural overview of La protein 
 
Research on the structure of La has been crucial in unveiling La’s complex functions, 
particularly in understanding its various binding modes. While the N-terminal domain (NTD) is 
highly conserved amongst eukaryotes, the C-terminal domain (CTD) of La is less conserved and 
can vary in length 50. Like many RNA-binding proteins, La is modular. The NTD harbours the La 
motif (LAM) and a RRM, followed by an a-helix (a3) (Figure 4). The C-terminal portion of La 
harbours a nuclear retention element (NRE) and a nuclear localization signal (NLS). In higher 
eukaryotes, a second RRM (RRM2) and a short basic motif (SBM) are found in the C-terminal 
domain. Hence, the size of La can vary from 32 kDa in lower eukaryotes such as yeast, which 
contains only one RRM, to 50 kDa in humans, which contains two RRMs 50.   
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Figure 4: Architecture of La orthologs in eukaryotes 
A schematic of the conservation between human La protein, D. melanogaster, C. elegans, S. 
pombe, S. cerevisiae, and T. brucei. The NTD is highly conserved and contains a La motif (LAM) 
and a RNA recognition motif (RRM), which are separated by a short linker sequence. The less 
conserved CTD of hLa harbours a second RRM, a nuclear retention element (NRE), a short basic 
motif (SBM), and a nuclear localization signal (NLS). The S. cerevisiae NLS is hypothesized to 
be a 113-amino-acid fragment within the RRM. With the exception of the C. elegans La protein, 
the remaining La proteins have demonstrated affinity for nascent RNA polymerase III transcripts. 
Figure adapted from49.  
 
 
The LAM is a highly conserved RNA binding domain that has been the focus of extensive 
research. This region is also found in several La related protein families and interestingly in a 
number of proteins that are structurally unrelated to La such as the polyribosome associated 
proteins Slf1p and Sro9p, both found in S. cerevisiae and are predicted to function in translation 
60. Several solved crystal and co-crystal structures of this domain demonstrates that the LAM has 
an α1α1α2β1α3α4α5β2β3 topology and contains amino acids that make UUU-specific contacts 
33,61–63 (Figure 5a). The LAM consists of a winged-helix-turn-helix shape in which many aromatic 
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residues are conserved 61,64. Dong et al. show that these aromatic residues are conserved in all 
characterized La proteins and in LAM containing proteins. Through structure based mutagenesis, 
six residues have been identified as being crucial for binding RNAs with 3' UUU-OH trailers. Of 
these, four residues are located in the conserved aromatic patch, and two are in close proximity. In 
addition, mutating an invariant aspartate (D27 in Trypanosoma brucei and D33 in hLa) in a 
hydrophobic pocket reduced La’s affinity for a 3'OH, but not for 3'PO4 groups. Although the ability 
of La to discriminate between the 3'OH ends of RNA Pol III transcripts and the 3'PO4 ends of 
degraded RNA was previously shown by Stefano et al., the structural analysis by Dong et al. 
provided the basis for this discrimination54,61.  
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Figure 5: Structure of the LAM, RRM1, and RRM2 
(A) The La module, consisting of the LAM and the N-terminal RRM, bind uridylate substrates by 
forming a binding cleft. The LAM consists of an α1α1α2β1α3α4α5β2β3 topology. High resolution 
co-crystal structures of the LAM reveal that when bound to the UUU-3'OH of an RNA, a winged 
helix portion of the LAM does not make any contact with UUU-3'OH and remains unoccupied. A 
small, flexible linker between the two domains adopts a helical conformation when bound to RNA. 
This allows both domains to assume proper conformations for RNA recognition. (B) The N-
terminal RRM has a β1α1β2β3α2β4a3 topology and is hypothesized to bind the body of the 
substrate. (C) The C-terminal RRM has a β1α1β2β3αβ4β4α3 topology and contains a canonical 
RNA binding β-sheet that is highly obscured by a C-terminal α-helix. Figure adapted from 65.  
 
 
 
Solved co-crystal structures demonstrated that the LAM and the RRM bind short oligo (U) 
ending RNAs through both stacking interactions and hydrogen bond formation 62,63.  While the 
majority of UUU-3'OH recognition is mediated by the LAM, the N-terminal RRM contributes 
minimally. The RRM has a β1α1β2β3α2β4a3 topology, with the a3 helix being atypical to the 
standard RRM fold 62 (Figure 5b). In concert, the LAM and RRM1 form a pocket that binds to 
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the UUU- 3'OH end of RNA substrates. As the LAM binds to the substrate, the canonical RRM1 
RNA binding surface is left relatively available to bind to other substrates. The RRM1 does not 
seem to play a crucial role in UUU-3'OH substrate recognition. Thus it is hypothesized that the 
RRM1 binds to substrates in an UUU-independent manner 62.  Mutational analysis indicates that 
the RRM1 may likely bind UUU-3'OH containing substrates upstream of the 3'OH end 40.   
While the function and mechanism of the LAM and RRM1 has been deciphered to some 
extent, the function of the RRM2 in hLa is still unclear. RRM2 has a β1α1β2β3αβ4β4α3 topology 
and contains a canonical RNA binding β-sheet that is highly obscured by a C-terminal α-helix 
33,41,66 (Figure 5c). Thus, both RRM1 and RRM2 have non-canonical a3 helices C-terminal to the 
RRM, although they appear to be in different orientations relative to the RRM’s RNA binding 
surface. It has been suggested that RRM2 may be involved in binding mRNA targets to enhance 
translation. Martino et al. hypothesize that the LAM, RRM1, and RRM2 synergistically enhance 
translation of viral mRNAs such as HCV, yet the mechanism is still unknown 41. The a3 helix 
following RRM2 contains the NRE, which is predicted to mediate the structure of the RRM2. 
Without the NRE, the tertiary structure of the RRM2 is destabilized 67. The NRE is followed by 
the SBM, whose function is not clear, but is hypothesized to modulate the access of 5' pre-tRNA 
leaders to RNase P via engagement of the 5' triphosphate 53. The NRE and the NLS are involved 
in the regulation of both nuclear and cytoplasmic activities. La can be phosphorylated at two sites, 
serine-366 (S366) by Casein Kinase 2 (CK2) and threonine-389 (T389) by AKT-1 68,69. 
Nucleoplasmic La is phosphorylated and associated with RNA pol III transcripts, whereas 
cytoplasmic La is typically non-phosphorylated and bound to RNA pol II transcripts 70.  
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1.2.3 Structural overview of La-related proteins (LARPS) 
 
La-related proteins (LARPs) contain the conserved LAM and are involved in gene 
expression at both the transcriptional and translational level (reviewed in 42,50,65,71). These proteins 
have been conserved through eukaryotic evolution, where through the use of modern bioinformatic 
and structural techniques, five LARP families have been identified in humans: Genuine La, 
LARP1, LARP4, LARP6, and LARP7 (Figure 6). Like La, the LARP family of proteins all 
contain a conserved 90-amino acid region called the LAM followed by an RRM, although the 
RRM structure varies between LARPs. Both La and LARP7 bear the typical canonical RRM1 
adjacent to the LAM. However, other LARPs lack the classical canonical RRM and instead have 
an RRM-like motif 42,50. The position of the La Module varies between different LARPs. For 
instance, while the La module is located near the N-terminus in genuine La, the La module is 
positioned more centrally in the other LARPs.  
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Figure 6: Architecture of the La protein and La-related proteins (LARPs) 
Schematic of genuine hLa and hLa-related protein families aligned at the conserved La motif 
(LAM). hLa consists of two RNA recognition motifs (RRM1 and RRM2), a nuclear retention 
element (NRE), a short basic motif (SBM), and a nuclear localization signal (NLS). LARP1 
consists of a RNA recognition-like motif (RRM-L5) and a DM15-repeat containing region, also 
known as the LARP1 motif. RNA recognition-like motifs are variations of the canonical RRM 
found in genuine La and are conserved across LARP families. LARP4 consists of another RNA 
recognition-like motif (RRM-L4) along with an atypical PAM2 domain (PAM2w). LARP6 
contains a RNA recognition-like motif (RRM-L3) and a SUZ-C domain. Lastly, LARP7 consists 
of two RRMs. Figure adapted from 50. 
 
 
 
 LARPs vary quite significantly in both their structure and function. LARP1 has two 
variants: LARP1a and LARP1b. A unique component of LARP1 is a D-repeat containing region 
(DM15)  found at the C-terminus 72. The DM15 region is comprised of triplicate amino acid repeats 
and has recently been shown to directly bind the 5' cap of TOP-containing mRNAs 42,73. LARP4 
also has two variants, LARP4a and LARP4b, both of which contain a PAM2w domain at the N-
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terminus ahead of the La Module that directly binds to PABP 39. LARP6 contains a SUZ-C motif 
in the C-terminal region, a 36 amino acid domain generally found at the C terminus of several 
RBPs believed to play a role in substrate recognition and protein localization 74,75. Based on 
sequence homology, LARP7 is most closely related to genuine La and the only LARP to contain 
a second RRM. 42. Although La and LARPs share the LAM, they are all structurally and 
functionally distinct. Over the past decade, continuous research has shed light on the functionality 
of the LARP family as these proteins have been found to bind to a wide range of RNA substrates, 
significantly contribute to cancer progression, and may potentially act as therapeutic targets for a 
wide range of diseases (further explained in section 1.5).   
 
1.3 The function of La in RNA metabolism 
1.3.1 The function of La in non-coding RNA metabolism  
 
Early studies examining La function and its targets were conducted using purified small 
ribonucleoprotein (RNP) complexes extracted from HeLa cells 54. Using anti-La sera, it was found 
that RNPs immunoprecipitated with La mainly consisted of RNAs ending in uridylate residues. A 
UUU-3'OH trailer is typically found in RNA polymerase III transcribed RNAs such pre-transfer 
RNAs (tRNAs), pre-5S ribosomal RNA (rRNA), and pre-U6 small nuclear RNA (snRNA). 
Similarly, La also recognizes and binds certain RNA polymerase II transcribed small RNAs 
including U1, U2, U3, U4, and U5 snRNAs. These small RNAs have poly(A) tails like other 
polymerase II transcripts. However, during processing they lose their poly(A) tail and leave behind 
a UUU-3'OH end 1. In addition, several studies have implicated La as associating with viral-
encoding RNAs including the adenovirus encoded VA-RNA1 and VA-RNA2, the Epstein-Barr 
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RNAs EBER1 and EBER2 as well as negative-strand viral leader RNAs 76–78. Using UV cross-
linking and RNA foot-printing assays, Mathews et al. confirmed that the binding site of hLa bound 
directly to the U-rich 3' tail of these RNA polymerase III transcripts, with a minimum of three 
uridines required for recognition 79. The requirements for the length of terminal uridines varies 
between organisms, with S. pombe requiring four or more terminal uridines and humans requiring 
a minimum of three terminal uridines 80. 
La is amongst one the first proteins to associate with nascent RNA polymerase III 
transcripts. La was originally hypothesized to play a role in RNA polymerase III transcription. 
During tRNA processing, the 5' leader of the pre-tRNAs is cleaved by RNAse P, while the 3'OH 
trailer is cleaved by RNAse Z 19. Endonucleases cleave the intron of the pre-tRNA and nucleotidyl 
transferases then add a CCA to the 3' end 53,81. Transcription is terminated when a stretch of poly-
uridylate residues are added to the 3' end by RNA polymerase III. It is believed that La remains 
bound to these UUU-3'OH ends until processing occurs to prevent exonuclease digest by Rex1p 
54,82,83 (Figure 7). During RNA processing and maturation, the terminal uridylates are usually 
removed resulting in the loss of the La protein binding site. Northern blot analyses on S. cerevisiae 
cell extracts show that without functional La, mutations in the secondary structures of several 
essential tRNAs and abnormal tRNA processing patterns arise 83. It is proposed that Lhp1p, the 
yeast La protein ortholog, stabilizes pre-tRNAs in conformations that allow 3′ endonucleolytic 
cleavage to occur. From this, it has been proposed that La does not have a direct role in 
transcription, but instead acts as an RNA chaperone to aid misfolded pre-tRNAs to achieve proper 
folding in order for protection against exonuclease digestion.  
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Figure 7: Precursor tRNA processing pathways in the presence and absence of La 
Four possible pathways exist which determine the fate of pre-tRNA. pre-tRNA fate determined by 
the length of the poly-U at the 3' end occurs when the interaction between the pre-tRNA and La is 
established with a minimum of three terminal U’s. The usual pathways of pre-tRNA processing 
occurs in the presence and absence of La, but processing of a defective pre-tRNA is only made 
possible in the presence of La. La engages nascent pre-tRNA transcripts and protects them from 
3' exonuclease activity, causing the 5' leader to be cleaved first by RNAse P followed by 3' end 
processing carried out by the 3' endonuclease RNAse Z. In the absence of La, cleavage of the 5' 
leader and the 3' trailer sequences occurs in the reverse order. A defective pre-tRNA cannot be 
properly processed in the absence of La, resulting in degradation. Figure adapted from 40. 
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1.3.1.1 La is an RNA chaperone 
One predicted function of La is that of an RNA chaperone 84. RNA substrates undergo 
several transition states during the folding process and these states present folding “traps” which 
prevent RNA from obtaining its native fold 85. RNA chaperones are proteins that aid in the 
unwinding and re-folding of RNA substrates into its native fold, which is essential for proper 
function. These proteins often display strand annealing and displacement activity to resolve these 
kinetic traps. The chaperone activity of La has been well studied in pre-tRNA substrates. Pre-
tRNAs often mis-fold as a result of DNA mutations, hypomodifications, or errors during 
transcription 86. 
 La is essential to prevent the degradation of pre-tRNAs by Rrp6, a component of the 
nuclear exosome that specifically targets defective pre-tRNAs, in a process called nuclear 
surveillance 86. Previous research has shown that certain amino acid residues in RRM1 are 
responsible for RNA chaperone activity. Using a cis-splicing assay which relies on the enhanced 
folding of a self-splicing intron in the presence of an RNA chaperone, Bayfield et al. found that 
mutating basic residues of the b2-b3 loop 3 region of hLa RRM1 resulted in compromised RNA 
chaperone activity 40. A few years later, using Fluorescence Resonance Energy Transfer (FRET) 
based analysis, Naeeni et al. further mapped the chaperone activity of La to the RRM1, in the a3 
helix as well as the disordered region in the linker before RRM2 84.  
In addition to acting as an RNA chaperone for pre-tRNAs, La is also hypothesized to act 
as an IRES trans-acting factor (ITAF) for mRNA translation 41,87. Many ITAFs are also RNA 
chaperones as these proteins bind to IRES containing cellular and viral mRNAs to induce 
conformational changes of the IRES and promote cap-independent translation (further explained 
in section 1.3.2) 87. A well-studied substrate of La that undergoes conformational changes is the 
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IRES of the Hepatitis C Virus. Circular dichroism spectroscopy (CD) analysis revealed that 
Domain IV of the Hepatitis C IRES undergoes minor conformational changes upon hLa binding 
41.  More recently, it has been shown that hLa binds near the start codon of the cyclin D1 mRNA 
(CCND1) and acts as an RNA chaperone to alter the structure of the cellular IRES to facilitate cap-
independent translation. However, this chaperone ability can be prevented through T389 
phosphorylation by AKT1 69. The ability of La to act as an RNA chaperone and the T389 binding 
site are both critical to promote IRES driven translation of the CCND1 mRNA. The RNA 
chaperone abilities of La also extend to microRNA (miRNA) processing in mammalian cells 88. 
La recognizes the stem loop structure of nascent pre-miRNAs and promotes miRNA biogenesis 
by protecting them from nuclease-mediated decay. The LAM, RRM1, and RRM2 are all 
implicated in recognizing and binding the stem loop region of miRNAs.  
 
1.3.2 The function of La in coding RNA metabolism 
While the function of La in the nucleus is becoming increasingly well-characterized, the 
function of La in the cytoplasm is still under investigation. Cytoplasmic substrates of La include 
upstream open reading frame (uORF) and 5' terminal oligopyrimidine tract (5' TOP)-containing 
mRNAs, as well as the IRESs of several viral and cellular mRNAs. Experiments by Meerovitch et 
al. in rabbit reticulocyte lysates (RRL) first demonstrated that La has the ability to enhance and 
correct aberrant translation of polioviral RNA 89. While La has been implicated in the enhancement 
of translation of several viral IRESs, many studies aimed at understanding the involvement of La 
in viral translation have been conducted using the highly structured HCV IRES located in the 5′ 
untranslated region (5' UTR) of the viral genome 41. This IRES consists of four domains: 1) 
Domain I is essential for viral translation, 2) Domain II enhances IRES activity, but is not 
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necessary for function 90, 3) Domain III has subdomains essential for the recruitment of ribosomes, 
and 4) Domain IV contains the start (AUG) codon. It was identified that La binds close to the 
initiator AUG and assists in the assembly of ribosomes in order for IRES-mediated translation to 
initiate 91.  
Martino et al. proposed a bipartite model for the interaction of hLa with Domain IV of the 
HCV IRES and speculate that the LAM, RRM1, and RRM2 are involved 41. It has been suggested 
that the LAM and the RRM1 are essential to interact with the single-stranded extension of the 
IRES element, while the RRM2 is involved in recognizing and binding the stem loop of the IRES. 
In these experiments, hLa displayed the same affinity for the stem loop when the nucleotide 
sequence was mutated but the same secondary structure was maintained, suggesting that La may 
be involved in recognizing the secondary structure of the stem loop instead of specific sequences. 
This research suggests a non-sequence specific mechanism by which La functions in the 
cytoplasm, and represents a novel finding where the RRM2 is implicated in binding a RNA 
substrate.  
Additionally, La has also been associated with the translation of human immunodeficiency 
virus type 1 (HIV1) 92. Svitkin et al. demonstrated that La binds the transactivation response 
element (TAR) at the 5' end of HIV1 mRNAs to form a stable hairpin structure that promotes 
translation, thereby alleviating translational repression. In addition to binding viral RNA and 
promoting viral replication, La has been implicated in binding the 5' terminal oligopyrimidine (5' 
TOP) tracts of many coding RNAs. These RNAs include ribosomal proteins and histone messenger 
RNAs 68,93,94. Using RNA immunoprecipitation chip (RIP-Chip) analysis, Inada et al. showed that 
Lhp1p in S. cerevisiae engages mRNAs in addition to the expected polymerase III substrates 59. 
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1.4 La association with cellular stress and cancer 
1.4.1 Cellular Stress 
 
The ability of cells to maintain active translation in response to cellular stress is vital for 
its survival. Cellular stress can be induced by a range of stressors including heat shock, oxidative 
stress, mitochondrial stress, and serum starvation resulting in a significant decrease in overall 
translation. Eukaryotic cells have evolved and adopted various mechanisms to adapt and overcome 
cellular stress or initiate apoptosis. Some of these mechanisms include the repression of cap-
dependent translation through the phosphorylation of eIF2α or the inhibition of mTORC1 and 
through the formation of stress granules to preserve cellular machinery95,96. Stress granules are 
dense aggregations composed of mRNAs and components of the cap-dependent translation 
machinery, translationally repressed mRNAs, PABP, and other RBPs 97,98. These membrane-less 
foci are hypothesized to protect stalled RNP complexes such that they can re-enter into polysomes 
when cells return to homeostasis97.   
The formation of these granules can be signaled by the phosphorylation of the α-subunit of 
eukaryotic translation initiation factor 2 (eIF2) causing inhibition of cap-dependent translation and 
the subsequent disassembly of polysomes. In unstressed cells, eIF2 serves to mediate binding of 
the initiator tRNA methionine (tRNAimet) to the 40S ribosomal subunit in a GTP-dependent 
manner 98. After initiation has occurred, eIF2 remains bound to GDP in an inactive state until 
recycled (Figure 8a) 99. In stressed cells, eIF2α is phosphorylated preventing the formation of the 
eIF2-GTP-tRNAimet complex, causing an inhibitory effect on translation. Depending on the 
particular stress, different kinases contribute to this phosphorylation (PERK for ER stress, PKR 
for viral infection, HRI for heat and osmotic shock, and GCN2 for glucose/ amino acid 
starvation)99. A cohort of RBPs, such as TIA1, TIAR and G3BP, are then recruited to these stalled 
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translation initiation complex and promote aggregation and formation of stress granules95,100,101.  
Stress granule formation can also be regulated by the mammalian target of rapamycin (mTORC1) 
complex. mTORC1 is a kinase complex that activates and regulates protein synthesis in response 
to various cellular and environmental factors including adequate energy resources, nutrient 
availability, oxygen and proper growth factor abundance 102,103. In unstressed cells, mTORC1 
phosphorylates 4E-BP, allowing eIF4E to bind eIF4G and promote protein synthesis (Figure 8b) 
104. However, during nutrient starvation, 4E-BP is dephosphorylated and bound to eIF4E, 
preventing the formation of the eIF4E/eIF4G complex103. This disruption in the formation of the 
eIF4F complex results in inhibition of translation initiation. Although these mechanisms disrupt 
the majority of translation during cellular stress, there is increasing evidence that cellular mRNAs 
containing IRES elements in their 5' UTR can escape recruitment into stress granules and remain 
actively translated even when cap dependent translation initiation is hindered 87,105,106.  
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Figure legend on next page. 
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Figure 8: Mechanisms for translation inhibition through eIF2a phosphorylation and 
mTORC1 inhibition 
(A) Certain stressors stimulate phosphorylation of eukaryotic initiation factor-2α (eIF2α). 
Depending on the type of stress, different protein kinases are activated: PERK for ER stress, PKR 
for viral infection, HRI for heme deficiency, and GCN2 for amino acid starvation. EIF2 consists 
of 3 subunits, eIF2α, eIF2β and eIF2γ. The three subunits form the ternary complex consisting of 
eIF2-GTP- and tRNAimet. The complex transports the initiator tRNA to the ribosome to form the 
43 preinitiation complex. During translation initiation GTP becomes hydrolyzed into GDP, a 
reaction catalyzed by eIF2β. Before each around of initiation, GDP is exchanged for GTP. During 
cellular stress, eIF2α is phosphorylated which inhibits the GDP-GTP exchange. This inhibition 
creates an inactive eIF2-GDP complex, thereby resulting in the inhibition of translation. (B) 
mTORC1 is a kinase complex that regulates protein synthesis. Initiation of cap dependent 
translation relies on the eIF4F complex, comprised of eIF4E, eIF4G, and eIF4A. The interaction 
between eIF4E and eIF4G is essential for proper function. In unstressed cells, mTORC1 
phosphorylates 4E-BP, allowing eIF4E to bind eIF4G and promote protein synthesis. However, 
during nutrient starvation, 4E-BP is dephosphorylated and bound to eIF4E, preventing the 
formation of the eIF4E/eIF4G complex. This disruption in the formation of the eIF4F complex 
results in inhibition of translation initiation. Figure adapted from 104,107. 
 
 
 
1.4.2 La protein involvement in cellular stress 
Previous work on viral infection and cellular stress have indicated that La is trafficked to 
the cytoplasm, with numerous reports citing increased association of La with IRES containing 
messages under different cellular stresses. Thus far, the IRESs identified as being associated with 
La under stress include the X-linked inhibitor of apoptosis protein (XIAP), the nuclear factor 
erythroid-2 related factor 2 (NrF2), the ribosome binding protein 1 (RRBP1), and the binding 
immunoglobulin protein (BiP) 56,108–110. 
One of the earliest reports linking La to an IRES containing mRNA is that of XIAP, a key 
regulator of programmed cell death (apoptosis) triggered by various apoptotic factors 108. Under 
conditions of serum deprivation and radiation-induced apoptosis, when cap-dependent translation 
is compromised, the XIAP IRES fosters efficient translation. Using gel mobility shifts, UV-
crosslinking, and bicistronic reporter assays, Holcik et al. demonstrated that La forms a stable RNP 
complex with the 5′ UTR of the XIAP IRES to stimulate IRES driven translation in HeLa cells. 
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While previous groups using RRL demonstrated that La binds the 5′ UTR of viral mRNAs to 
stimulate their translation, Holcik et al. were the first to validate that La also binds cellular mRNAs 
through the use of both in vitro and in vivo assays and showing that La directly binds the XIAP 
IRES to modulate XIAP translation. 
In a study conducted by Zhang et al., it was shown that nuclear La can migrate into the 
perinuclear space to engage the NrF2 IRES in response to oxidative stress 109. The NrF2 protein is 
a transcription factor that controls gene expression of detoxification genes and is a master regulator 
of oxidative stress response through its control of expression of antioxidant and detoxification 
genes. The 5′ UTR of NrF2 contains an IRES element, predicted to be a substrate of La. 
Immunofluorescence staining of HeLa cells displayed a cytoplasmic distribution of La only 10 
minutes following treatment with 100µm hydrogen peroxide (H2O2). Tandem mass spectrometry 
coupled with liquid chromatography (LC-MS/MS) along with various in vitro and in vivo RNA 
binding assays, confirmed the direct binding of La to the NrF2 IRES in response to H2O2 treatment. 
Thus, it was concluded that oxidative stress results in the nuclear export of La to the cytoplasm 
and increased association with the NrF2 5′ UTR.  
Similarly, Chan et al., reported that oxidative stress results in the increased binding of La 
to the HCV IRES 111. Oxidative stress is a prominent feature of patients diagnosed with Hepatitis 
C and elevated levels of reactive oxygen species (ROS), and reduced antioxidant levels have been 
detected in both the blood and liver. It was demonstrated that oxidative stress upregulates HCV 
IRES driven translation resulting in the translocation of La to the cytoplasm. In vitro translation 
assays revealed increased La driven cap-independent translation of the HCV IRES upon oxidative 
stress in the hepatocellular carcinoma cell line HuH7. The link between how oxidative stress 
positively affects the ability of La to promote viral replication and the mechanism by which the 
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HCV IRES induces La cytoplasmic distribution in response to oxidative stress is yet to be 
established. Further studies examining the interaction of La with other picornaviral and HCV-like 
IRESs during oxidative stress conditions may reveal more information about the mechanism 
through which La is recruited to the cytoplasm to promote IRES dependent translation and viral 
replication.  
It has been shown that serum-starvation of both human embryonic kidney (HEK293T) and 
human hepatocellular carcinoma (Bel7402) cells results in the cytoplasmic localization of La and 
increased La driven translation of the RRBP1 mRNA 110. RRBP1 is an ER membrane protein 
involved in ribosome binding and translocation of nascent proteins, particularly across the rough 
ER. Increased expression of RRBP1 is observed in some tumour cells implicating RRBP1 in the 
maintenance of malignancy and adaptation to ER stress. RRBP1 was identified as having an IRES 
element, which cells rely on to survive during serum starvation, a condition during which they are 
more susceptible to apoptosis. Serum starvation of Bel7402 cells resulted in increased association 
of La with both the RRBP1 and the XIAP IRES. Through this study, it was established that La is 
a positive activator of the RRBP1 IRES in vivo, under serum starvation conditions.  
Similarly, the cytoplasmic re-localization of La has been observed in cells from the human 
salivary gland (HSG) of patients with Sjögren’s syndrome (SS) 112.  Salivary gland epithelial cells 
from SS patients secrete fluid rich with a diversity of proteins, a process supported by a hyperactive 
ER, eventually ending in cellular apoptosis. As a response to the increased ER activity, the 
unfolded protein response (UPR) is activated to re-establish homeostasis. BiP, a known substrate 
of La, is also a key player in the UPR and is essential for the folding of misfolded or unfolded 
proteins within the ER 113. It is proposed that ER stress-induced apoptosis induces the cytoplasmic 
redistribution of La to cluster both around and at the surface of the apoptotic bodies in order to 
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bind the BiP mRNA 112. La also has increased association with BiP during Human cytomegalovirus 
(HMCV) infection. Certain viruses, such as the HCMV, inflict stress on cells in order to benefit 
from already existing translational machinery to promote their own viral replication 114. By 
inducing ER stress and modulating the UPR in infected cells, HCMV activates BiP to perform its 
ER chaperone activities. Consequently, increased activation of the BiP IRES and increased levels 
of La are observed in HCMV infected cells. Knockdown of La results in both the loss of BiP IRES 
activity and a reduction of BiP protein levels. It is concluded that infection by HCMV results in 
increased BiP levels in part due to the ability of La to promote cap-independent translation of the 
BiP IRES. Although several studies have demonstrated the translocation of nuclear La to the 
cytoplasm under compromised cellular conditions, the mechanism by which this occurs has yet to 
be established.  
 
1.4.3 La protein involvement in cancer 
 
The La protein has been linked to cancer related mRNA metabolism, particularly due to its 
association with the cancer related targets Cyclin D1, Laminin B1, and Murine double minute 2 
(MDM2) 56,58,115,116. Sommer et al. observed elevated La protein expression in squamous cancers 
of the head, neck, and cervix to drive migration and invasion. Elevated levels of La correlated with 
aberrant levels of CCND1 and it was established that La binds the IRES of the CCND1 mRNA to 
promote IRES dependent translation, contributing to proliferation 58. Furthermore, studies show 
that La binds near the CCND1 start codon and acts as an RNA chaperone to alter the structure of 
the IRES to facilitate cap-independent translation. However, this chaperone ability is deterred by 
T389 phosphorylation by AKT1 69. It has been concluded that both the ability of La to act as an 
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RNA chaperone along with the T389 binding site are critical to promote IRES driven translation 
of the CCND1 mRNA. 
La has also been implicated in chronic myelogenous leukemia (CML) through its 
association with the MDM2 mRNA. CML is triggered by a mutation generating the BCR-ABL1 
fusion oncogene, producing abnormal myeloid cells which proliferate in bone marrow and 
eventually migrate into the bloodstream. The BCR-ABL1 gene is formed when the ABL gene from 
chromosome 9 joins to the BCR gene on chromosome 22, to form the BCR-ABL fusion gene 117. 
Increased expression of La and MDM2 have been detected in BCR-ABL1-expressing myeloid 
precursor cell lines 116. Trotta et al. demonstrated that the ability of La to recognize and bind to a 
conserved sequence in the intercistronic region of MDM2 mRNA is necessary for MDM2 protein 
expression. Moreover, it was shown that the levels of MDM2 and La are proportional, wherein the 
down-regulation of La leads to a decrease in MDM2, while overexpression of La results in 
increased MDM2 expression. Since MDM2 is an essential negative regulator of the p53, a guardian 
of the genome and vital tumour suppressor, this positive correlation suggests that La can indirectly 
affect the expression levels of p53. It has been hypothesized that the BCR-ABL1 oncogene leads 
to p53 inactivation, as CML patients often possess inactivating mutations of the p53 gene. Thus, 
this suggests that the interaction of La with MDM2 can indirectly lead to the progression of cancer 
through the functional inactivation of p53. 
The involvement of La protein in the epithelial to mesenchymal transition (EMT) through 
its association with the Laminin B1 IRES was first identified by Petz et al 115. EMT results in 
epithelial cells losing their cell to cell adhesion contacts and becoming malignant, possessing both 
migratory and invasive properties. This leads to their transition into mesenchymal stem cells, cells 
susceptible to differentiation and formation of new cell types. The laminins are a family of 
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glycoproteins found in the extra cellular matrix, and involved in the migratory behavior of 
malignant cell types. Specifically Laminin B1, promotes cell adhesion, motility, and differentiation 
and is over-expressed in metastatic cancers  such as hepatocellular carcinoma (HCC) 118. Using 
bicistronic and RNA affinity assays, it was shown that through its associations with the Laminin 
B1 IRES, La indirectly promotes translational upregulation during hepatocellular EMT. 
 
1.5 La-related protein function in RNA metabolism 
1.5.1 LARP1 
While the La protein functions in facilitating the processing of RNA polymerase III and 
RNA polymerase II transcripts, the LARPs have evolved to target only one of these classes. 
Although structurally different, there exist many similarities between substrates and functionality 
of genuine La and the LARPs. The LARP1 family has diverged the most from genuine La. LARP1 
was first identified in Drosophila and is required for embryogenesis, oogenesis, spermatogenesis, 
formation of the mitotic spindle poles, successful segregation of mitochondria, and cell cycle 
progression 119–121. In humans, LARP1 can be found in both the nucleus and the cytoplasm, but is 
predominantly cytoplasmic and associated with mRNA translation, stability, and decay 122. Using 
co-immunoprecipitation, Aoki et al. initially reported that LARP1 promotes translation of 5' TOP 
containing mRNAs by binding directly to the poly(A) tail to stabilize the structure of the translating 
message 123.  Later, Tcherkezian et al. added to this hypothesis by revealing that LARP1 promotes 
translation of 5' TOP containing mRNAs via direct interaction with PABP and other cap binding 
elements, an interaction mediated the DM15 region 124.  
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While non-phosphorylated LARP1 interacts with both the 5'- and 3' UTR of mRNAs to 
inhibit their translation, phosphorylated LARP1 dissociates from the 5' UTR and activates 
translation. In the recent years, great focus has been placed on the involvement of LARP1 with the 
mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis. mTORC1 is a 
protein complex that activates and regulates protein synthesis in response to various cellular and 
environmental factors including adequate energy resources, nutrient availability, oxygen and 
proper growth factor abundance 102. In conditions where mTORC1 is inhibited, such as oxidative 
stress or nutrient starvation, LARP1 is hypothesized to displace the eukaryotic translation initiation 
factor 4G (eIF4G) from the 5' cap to form a bridge between the 5' TOP sequence and the poly(A) 
tail (Figure 9). By displacing eIF4G, LARP1 creates a closed loop in which translation is inhibited. 
However, when protein synthesis and mTORC1 are active, LARP1 forms a translationally active 
open-loop confirmation to bind PABP to promote translation. A structure based study by Lahr et 
al., identified the DM15 region of LARP1 as binding directly to the 7-methylguanosine cap of 5' 
TOP mRNAs 73. Interactions of LARP1 with the cap and adjacent 5' TOP motif inhibits binding 
of eIF4E to the cap, thereby preventing the assembly of the eIF4F complex.  
 
 35 
 
 
 
Figure 9: Schematic of hypothesized LARP1 mediated translation of TOP mRNA 
LARP1 is hypothesized to both positively and negatively regulate 5' TOPs in response to activation 
of the mTORC1 pathway. When mTORC1 is inhibited under conditions of cellular stress, LARP1 
displaces eIF4G from the 5' cap and binds the 5' TOP sequence, the 5' cap, and the poly(A) tail 
creating a closed loop formation that is translationally inactive. LARP1 also prevents eIF4E from 
binding to the cap, thereby blocking the assembly of the eIF4F complex. However, when mTORC1 
is activated, 4E-BP1 is phosphorylated releasing eIF4E to join the eIF4F complex. Simultaneously, 
LARP1 is recruited to bind PABP producing an mRNA in an open-looped formation that is 
translationally active. Figure adapted from 125. 
 
LARP1 is associated with several types of cancers including cervical, prostate, breast, and 
hepatocellular 71,126. Knockdown of LARP1 in cervical cancer cell lines such as HeLa using RNA 
interference (RNAi) causes cells to undergo apoptosis 127. In prostate cancer cells, knockdown of 
LARP1 results in attenuation of tumour migration. It was also shown that the LARP1 mRNA is a 
direct target of miR-26a and miR-26b, two miRNAs that are significantly downregulated in cancer 
128. Loss of these tumour-suppressive miRNAs in prostate cancer cells enhances invasion through 
direct regulation of LARP1. In breast cancer, a spliced variant of LARP1 has been identified 
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suggesting that splicing may occur to alter the conformation of binding domains to bind to different 
RNA substrates 129. 
1.5.2 LARP4 
Similar to LARP1, the LARP4 family has been implicated with mRNA translation. LARP4 
has two variants, LARP4a and LARP4b, which share only 38% homology 42. Although LARP4 
does not contain a DM15 motif or a second RRM, it does contain a non-canonical PAM2 domain 
(PAM2w). It is hypothesized that both the LAM and PAM2w directly bind PABP to promote 
translation 39,130,131. Both LARP4a and LARP4b are believed to promote mRNA translation via 
direct interactions with PABP and the ribosome-associated receptor for activated C kinase 1 
(RACK1), a 40S ribosome and mRNA associated kinase 39,132. While mammalian LARP4a 
displays affinity for poly(A) RNA, suggesting it could bind to mRNA poly(A) tails, LARP4b binds 
to AU-rich regions in the 3' UTR of mRNAs, implying that these proteins may have distinct 
functions. It is hypothesized that LARP4b stabilizes the circular conformation of mRNAs by 
binding both PABP and RACK1 to promote protein synthesis 132. Recent studies have shown 
LARP4 to be a vital regulator of cancer cell migration and invasion. Knockdown of both LARP4a 
and LARP4b has resulted in increased migration of prostate cancer cells and elevated mRNA 
levels of the tumour suppressor genes p16 and p19, suggesting that LARP4 may play a crucial role 
in tumour suppression 133. 
1.5.3 LARP6 
LARP6, originally called Acheron, was first identified in the moth Manduca sexta when 
studying programmed cell death during development of intersegmental muscles 134,135. Found 
predominantly in neurons, striated skeletal muscle, and cardiac muscle, LARP6 plays a key role 
in differentiation, proliferation, and apoptosis of myoblasts-nascent muscle fibers 120. In addition, 
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this protein influences cell adhesion, morphology, and cytoskeletal organization. LARP6 shuttles 
between the nucleus and cytoplasm, and participates in the nuclear export and regulation of type I 
collagen mRNAs, the most abundant vertebrate structural protein 136. A unique feature of LARP6 
is the conserved SUZ-C motif in the C-terminus believed to participate in substrate recognition 74. 
Type I and type III collagen mRNAs contain a unique conserved stem-loop structure in the 5' UTR. 
LARP6 binds to the 5' stem-loop structure in a sequence specific manner to stabilize mRNA and 
affect its translation 137,138. While the ability of LARP6 to bind collagen mRNA was originally 
attributed to the LAM along with an additional 40 amino acid motif at the N-terminal that is absent 
from other LARPs, recent studies suggest that the inter-linker domain between the LAM and the 
RRM within the La module may play a critical role in facilitating this binding 139. Generally, 
LARP6 acts as an oncogene by enhancing angiogenesis and tumor growth, and has been found to 
be highly expressed in breast cancer in the myoepithelial cells of the mammary gland 140.  
1.5.4 LARP7 
Human LARP7 mediates the transcription and regulation of the 7SK RNA by binding, in 
a sequence specific manner to the UUU-3'OH end 141,142. The abundantly expressed non-coding 
7SK RNA controls eukaryotic transcription by regulating the activity of the positive transcription 
elongation factor b (P-TEFb), a cyclin dependent kinase required for RNA polymerase II 
transcription elongation 143. By binding to both the UUU-3'OH and the 5' capping protein 
methylphosphate capping enzyme (MePCE), LARP7 circularizes the 7SK snRNP to create a stable 
structure protected from exonuclease digestion.  
In addition to binding the U-rich sequence at the 3'OH end of the 7SK RNA, LARP7 also 
recognizes and binds a 3' hairpin loop structure near the U-rich tail. These interactions have been 
mapped to the LAM, the RRM1, and RRM2 in tandem. The complex of LARP7 bound to the 7SK 
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RNA suppresses the P-TEFb complex, thus suppressing transcription 144. Knockdown of LARP7 
using RNAi results in transcriptional elongation due to 7SK RNA degradation which results in P-
TEFb activation. Deletion of the C-terminal RRM results in gastric cancer tumorigeneses, 
suggesting that the C-terminal RRM plays a crucial role in its interaction with 7SK RNA and that 
LARP7 is a potential tumour suppressor 145,146. Analysis of breast cancer tissue from patients show 
extremely low levels of LARP7 and increased levels are observed in cancer survivors, further 
confirming the oncogenic role of this protein 147.  A summary of the La-related protein families, 
their substrates, and functions are listed in Table 2.  
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Table 2: Summary of LARP families with their functions and substrates. Modified from71 
  
 La/SSB LARP1a LARP1b LARP4a LARP4b LARP6 LARP7 
Role in 
transcription 
Protects Pol III 
transcripts and 
maturation of 
pre-tRNA and 
non coding 
RNAs 
- - - - 
Interacts with 
transcription 
factors, 
vimentin, non 
muscle myosin 
Binds 7SK 
snRNP and 
negatively 
regulates RNA 
pol II 
transcription 
Role in 
translation 
IRES mediated 
and 5'TOPs 
Regulates the 
stability and 
translation of 
mRNAs 
- 
Promotes 
mRNA 
stability 
Stimulates 
translation and 
circularizes 
mRNAs 
Promotes 
translation of 
collagen 
- 
Known 
mRNA targets 
IRES and 
5'TOP mRNAs 
mRNAs 
containing 
5'TOPs and 
mTOR, 5'cap 
of mRNA 
- 
Single 
stranded 
poly(A) 
stretches 
- Type 1 collagen - 
Protein 
binding 
partners 
- 
Raptor, 
eIF4E, 
eIF4A, 5'cap 
- RACK1, 40S components 
RACK1, 40S 
components 
Filaments, RNA 
helicase, non 
muscle myosin 
MePCE 
Binds PABP? - yes  yes yes yes no 
Substrate 
recognition 
motifs 
stem loop in 
IRES mRNAs 
and miRNAs, 
and 3'trailer of 
Pol III 
transcripts 
5'end of TOPs - - - 5'stem loop in alpha collagen 
3'end of 7SK 
RNA 
Associated 
cancers 
head, neck, 
liver, cervix 
cervix, liver, 
breast, 
prostate, lung 
- prostate acute myeloid leukemia breast 
cervix, gastric, 
breast 
Tumor 
suppressor or 
oncogenic? 
proto-oncogenic proto-oncogenic - 
tumor 
suppressor 
proto-
oncogenic proto-oncogenic tumor suppressor 
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While the genuine La protein assists in both processing of RNA polymerase III and RNA 
polymerase II transcripts, the various LARP families target only one of these classes. The LARP7 
family is most closely related to genuine La both functionally and structurally. Like La, members 
of the LARP7 family bind RNA polymerase III transcripts using a UUU-3'OH dependent RNA 
binding mode and assist in transcription. Members of the LARP1, LARP4, and LARP6 families 
are predominantly involved in various aspects of mRNA stability and translation, and have been 
reported to interact with PABP. Of these, both human LARP1 and LARP4 have been shown to 
directly engage poly(A) and demonstrate affinity for adenylates in a length dependent manner. 
However, the mechanism through which these LARPs engage poly(A) sequences is still unknown. 
LARP6 binds to the 5' stem-loop structure of collagen mRNAs in a sequence specific manner. The 
ability of the La/LARP families to bind such a vast range of substrates is attributed to subtle amino 
acid variations within the La Module along with the diverse domains found in each of these 
proteins (e.g., DM15 in LARP1 and PAM2w in LARP4). Further structural and biochemical 
studies will reveal novel targets and functions of the LARP families. 
1.6 Summary and Statement of Purpose 
La proteins are present in nearly all eukaryotes and have conserved functions in facilitating 
the processing of RNA polymerase III transcripts. hLa is an RNA-binding phosphoprotein that 
shuttles between the nucleus and cytoplasm interacting with various RNA substrates 46,52. Human 
La phosphorylated at S366 is typically found in the nucleus and involved in the processing of RNA 
polymerase III transcripts such as U6 snRNA, tRNA precursors, or pre-5S rRNA and serves to 
protect transcripts from 3'-5' exonuclease degradation by binding the UUU 3'OH trailer in a 
sequence specific manner 53,54,79. While the interaction of La with substrates that end with the 
uridylate trailer has been well characterized, its interaction with substrates that lack this trailer is 
 41 
still under investigation. Non-phosphorylated hLa, found in the cytoplasm, binds and enhances the 
expression and translation of cellular and viral mRNAs through the use of the IRES, 5' TOPs, and 
uORFs. La associated viral IRESs include Hepatitis C, Hepatitis B, encephalomyocarditis viruses, 
and poliovirus 41,57,87. La associated cellular IRESs include BiP, Laminin B1, XIAP, and CCND1 
56,58,108,115. These cytoplasmic substrates are often involved in cell cycle regulation, apoptosis, 
tumour suppression, and stress responses, signifying a potentially important role for La during 
cellular stress conditions. Although La proteins are hypothesized to promote cap-independent 
translation of these coding RNAs, the context and mechanism by which La binds and affects 
translation of coding RNAs has yet to be established. 
The objective of this study is to further understand the mechanisms by which La affects 
translation and interacts with its cytoplasmic targets, as these structures lack a UUU-3'OH trailer. 
Like hLa, certain LARP families, specifically hLARP 1 and 4, have also been implicated in mRNA 
translation and protein expression through their contacts made with the poly(A) tail directly and/or 
with PABP 39,124,132.  Given the established role of both La and the La-related proteins in the 
translation of cellular mRNAs, we began by testing whether La also regulates mRNA translation 
via contacts made through the poly(A) tail. In Chapter 2, we show that in addition to sequence 
specific UUU-3'OH binding, hLa exhibits a sequence specific and length dependent poly(A) 
binding mode and that La may regulate IRES mediated translation through contacts made with the 
poly(A) tail. Using electromobility shift assays (EMSA) and CLIP, we show that hLa exhibits a 
sequence specific and length dependent poly(A) binding mode. Through mutational analysis, we 
mapped this poly(A) binding mode to the winged helix face in the LAM previously shown to be 
vacant during uridylate binding. We also show La entry into polysomes utilizes the poly(A) 
binding mode and that the ability of La to promote translation using the CCND1 IRES occurs 
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competitively with PABP. These results provide a mechanism through which hLa may interact 
with its cytoplasmic substrates to drive cap-independent translation. 
The second aim of this study is to understand the cellular context in which La interacts 
with its cytoplasmic substrates. Several reports have shown that during conditions of viral 
infection, cellular stress, and tumour progression, the predominantly nuclear hLa protein can 
translocate to the cytoplasm where it functions as an ITAF, controlling cap-independent translation 
initiation of several cellular IRES-containing mRNAs. These La associated cytoplasmic substrates 
are often involved in cell cycle regulation, apoptosis, tumour suppression, and stress responses, 
signifying an important role for La during cellular stress conditions. However, the mechanism for 
the shuttling of La during cellular stress seems to be context specific. Thus in Chapter 3, we 
investigate the conditions that initiate this translocation and identify novel stress associated 
substrates of hLa. We show that cellular stress induced by the mitochondrial inhibitor clotrimazole, 
can induce translocation of hLa from the nucleus to the cytoplasm. In addition, using polysome 
analysis and qPCR, we show that translocation of La to the cytoplasm is concurrent with increased 
La association with actively translating messages. Using iCLIP, we identified specific messages 
that La interacts with during stress and monitored changes in La association with these messages 
in the presence and absence of cellular stress. Taken together, this study reveals a novel binding 
mode and mechanism of action for hLa and demonstrates that hLa is trafficked into the cytoplasm 
in response to cellular stress in order to associate with stress-related messages and promote cap 
independent translation.  
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2.1 Summary 
 
In addition to a role in the processing of nascent RNA polymerase III transcripts, La 
proteins are also associated with promoting cap-independent translation from the internal ribosome 
entry sites of numerous cellular and viral coding RNAs.  La binding to RNA polymerase III 
transcripts via their common UUU-3'OH motif is well characterized, but the mechanism of La 
binding to coding RNAs is poorly understood. Using electromobility shift assays and cross-linking 
immunoprecipitation, we show that in addition to a sequence specific UUU-3'OH binding mode, 
human La exhibits a sequence specific and length dependent poly(A) binding mode. We 
demonstrate that this poly(A) binding mode uses the canonical nucleic acid interaction winged 
helix face of the eponymous La motif, previously shown to be vacant during uridylate binding.   
We also show that cytoplasmic, but not nuclear La, engages poly(A) RNA in human cells, that La 
entry into polysomes utilizes the poly(A) binding mode, and that La promotion of translation from 
the cyclin D1 internal ribosome entry site occurs in competition with cytoplasmic poly(A) binding 
protein (PABP).  Our data are consistent with human La functioning in translation through contacts 
to the poly(A) tail. 
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2.2 Introduction 
 
La proteins have been characterized in nearly all eukaryotes examined and have conserved 
functions in the processing of RNA polymerase III transcripts 42.  First identified as an autoantigen 
in patients suffering from systemic lupus erythematosus and Sjögren’s syndrome 45,148, 
immunoprecipitations using anti-La antibodies revealed that human La (hLa) associates with 
precursor forms of RNA polymerase III transcripts 55,76,149 as well as the uridylate-tailed adenoviral 
VA RNA and the Epstein-Barr virus encoded EBER RNAs 150,151.  The importance of the uridylate 
tail was subsequently validated by experiments showing that the number of uridylates directly 
influenced the efficiency of La binding to a pre-tRNA or VA RNA substrate, with high-affinity 
binding generally requiring at least three terminal uridylates 54,79.  Subsequent structural and 
biochemical work deciphered the specific mechanism of UUU-3'OH recognition, in which the 
UUU-3'OH motif is sandwiched between the N-terminal La motif (LAM) and RNA recognition 
motif (RRM1; together the so-called “La module”).  Furthermore it was demonstrated that 
uridylate specific contacts are mediated largely by conserved amino acids on the La motif 62,63.  
Surprisingly, these structures indicated that neither of the expected nucleic acid binding surfaces 
of the La module (the winged helix interaction surface of the LAM nor the b-sheet of RRM1) 
contribute to UUU-3'OH recognition 62,152, leaving the function of these canonical interaction 
surfaces unclear.   
In addition to a sequence-specific UUU-3'OH-dependent binding mode, other work using 
a variety of substrates has demonstrated that the canonical RNA binding surface of RRM1, RRM2 
and the disordered CTD also contribute to La RNA binding in a relatively non-specific manner 
40,41,153,154.  The canonical RNA binding surface of RRM1 enhances human La binding to the main 
body of pre-tRNAs, which in combination with the UUU-3'OH dependent binding modes, assists 
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La in the discrimination of pre-tRNA processing intermediates 40,155.  The RRM1, RRM2 and 
disordered C-terminal regions of La have also been implicated in RNA binding via modes that 
lack sequence specificity but can nevertheless rely on the presence of RNA secondary structure 
41,153,156.  For example, the La motif, RRM1 and RRM2 all contribute to the binding of a small 
hairpin with a short, single-stranded 3' tail derived from the Hepatitis C IRES, and while the 
presence of the hairpin and single stranded extension were both shown to be critical for maximal 
binding, the actual sequence of these was much less important 41.   Often, these UUU-3'OH 
independent binding modes have been implicated in La function as an RNA chaperone. RNA 
chaperone activity in human La has been mapped to the RRM1 as well as the disordered CTD 
84,154, and it has been proposed that one of the functions of the UUU-3'OH depending binding mode 
is to recruit non-specific La-associated RNA chaperone activity to UUU-3'OH containing 
substrates 157. It is thus hypothesized that binding of La to RNA targets in vivo occurs through the 
co-operation of a number of RNA binding modes in combination 41,49, and that the specificity 
determinants for some of these binding modes are still nebulous. 
Consistent with the presence of UUU-3'OH independent La-RNA binding modes, La 
proteins also immunoprecipitate coding RNAs lacking this motif 52,59.  Human La was identified 
as the first internal ribosome entry site (IRES) trans-acting factor (ITAF) due to its ability to 
enhance translation of polioviral RNA 158, and has since been shown to likewise enhance cap-
independent translation of other (+) stranded viral RNAs associated with challenges to human 
health.  IRESs are also found in some cellular mRNAs, and it has been hypothesized that these can 
be more efficiently translated under conditions of cellular stress (reviewed in 159).  Consistent with 
a role in the translation of RNA polymerase II transcripts, La immunoprecipitates mRNAs in a 
variety of experimental systems, including yeast, Xenopus oocytes, and human tissue culture cells 
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52,59,160.  La promotes IRES based translation from several cellular mRNAs, including those 
encoding BiP, cyclin D, NRF2 and laminin B1, as well as the upstream open reading frame (uORF) 
containing mRNA for the oncogene MDM2 56,58,109,115,116.  The effect of La on classical cap-
dependent translation is less well understood, with various studies indicating that La can activate 
or inhibit cap-dependent protein synthesis, suggesting that La influence in this process may be 
context specific (reviewed in 50).  While the mechanism by which La proteins recognize coding 
RNAs is still poorly understood, it has been hypothesized to rely on electrostatic, RNA structure 
dependent contacts mapping largely to the RRM1 and RRM2 domains (in those La proteins that 
harbour a second RRM) 41,50.  Importantly, a sequence specific RNA binding mode for La targets 
that lack UUU-3'OH has yet to be characterized.    
Recently, the study of human La has substantially expanded into the study of the human 
La-related proteins (hLARPs), which similar to hLa share a La-motif and can harbour RNA 
chaperone activity but are hypothesized to bind RNA targets distinct from those of La 42,50,161.  
Like La, the hLARPs 1, 4 & 4b have also been implicated in the control of protein translation.  
Notably, these La-related factors are hypothesized to associate with the poly(A) tail directly and/or 
through interactions with poly(A) binding protein 123,124,132,162,163.  However, a mechanism by 
which the LARPs may engage poly(A) sequences is still lacking. Given the established role of La 
and the La-related proteins in the translation of cellular mRNAs, we decided to test whether La 
might contact mRNAs, at least in part, through the poly(A) tail.   In this work, we demonstrate that 
human La specifically binds poly(A) RNA in vitro with significantly higher affinity than other 
non-uridylate homopolymers, provided the RNA sequence is extended (i.e twenty nucleotides), as 
is common in the poly(A) tails of mRNAs.  We also show the canonical winged-helix face of the 
La motif plays a role in poly(A) but not UUU-3'OH binding, as mutagenesis of this region impairs 
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a) poly(A) binding in vitro, b) entry of cytoplasmic La into polysomes c) crosslinking 
immunoprecipitation (CLIP) of poly(A) tails in human cells and d) translation from a bicistronic 
cyclin D1 IRES containing reporter construct. Together, our data are consistent with a model in 
which two specific binding modes (UUU-3'OH and poly(A)) direct La RNA chaperone activity to 
its two classes of RNA substrate in their respective cellular compartments.  The importance of the 
La motif in poly(A) binding may also have relevance for the mechanism of how the cytoplasmic 
La-related proteins associated in translation perform related functions. 
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2.3 Materials and Methods 
 
Electromobility shift assays (EMSAs)  
All radiolabelled RNAs were PAGE purified after 5' end labeling. Recombinant His-tagged human 
La 164 or hLa point mutants (generated by QuikChange; Agilent) were purified from E. coli first 
over a Ni++ column (His-Trap, GE-Amersham) then a heparin column (Hi-Trap, GE-Amersham). 
Proteins were then concentrated and quantitated via Bradford and SDS-PAGE, and A260/A280 
ratios were taken to confirm purified proteins were free from contaminating RNAs that might have 
co-purified from E. coli.  EMSAs were performed as described 40. Briefly, 3000 cpm 
(approximately 0.1 nM) of various RNA substrates (IDT) were incubated with various 
concentrations of recombinant human La or human La mutants in a 20 µl reaction containing 1X 
EMSA buffer (20 mM Tris pH 7.6, 100 mM KCl, 1mM EDTA and 5 mM b-mercaptoethanol) and 
50 ng HepC (5' rCrGrU rGrCrA rCrCrA rUrGrA rGrCrA rCrGrA rArUrC rCrA 3' 41) or 10 ng C10 
as cold RNA competitor. RNAs were initially slow-cooled from 95°C to room temperature and 
then incubated with protein at 37°C for 20 minutes. Complexes were resolved on 10% (w/v) 
polyacrylamide nondenaturing gels at 4°C at 100V.  Supershifts were treated as supplementary 
binding events to the primary binding event, and binding curves were fit using a non-linear specific 
binding curve fitting program (GraphPad, Prism). Kd values were approximated as the 
concentration of protein at which half of the RNA substrate was bound.   
For competition experiments, radiolabelled RNAs were mixed with indicated amounts of cold 
RNA in 1X EMSA buffer, after which 2uM recombinant hLa was added and incubated for 20 
minutes at 37oC, prior to separation on native PAGE as described above. 
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Cross-linking Immunoprecipitation (CLIP)  
CLIP was performed as described 27 with the following modifications.  Briefly, two 15cm dishes 
of HEK293T cells per CLIP were transfected with pEGFPC1-hLa 70, or indicated GFP-hLa 
variants or myc-tagged pcDNA-PABPC1 165  (PolyJet, SignaGen).  24 hours post transfection cells 
were UV-crosslinked (Stratalinker at 254 nm, 1000 mJ) and cells were lysed in RIPA buffer (10 
mM Tris-HCl pH8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 
mM NaCl, 1 mM PMSF).  Lysates were then treated with 3µl of 1:100 RNAse I (100U/µl AM2294 
Invitrogen) or 40 µl of a 1:100 dilution of RNase T1 (1U/µl AM2283 Ambion) and 2 µl DNase I 
(2U/µl AM2238 Ambion) at 37oC for 3 mins.  Antibodies used were anti-cmyc (Abcam ab21060) 
or anti-GFP (Abcam ab1218). coIPs were performed using Protein G magnetic Dynabeads 
(Invitrogen). Antibodies were incubated with Dynabeads in 150 µl RIPA buffer for one hour at 
room temperature, then antibodies/Dynabeads were incubated with lysates for two hours at 4oC.   
Complexes were washed 2x with RIPA buffer and 3x with proteinase K buffer prior to digestion 
with 10 µl proteinase K (buffer and enzyme supplied by Invitrogen, #100005393 20mg/mL). 
Eluted RNA was probed with 32P radiolabeled dT(40), stripped and reprobed for pre-tRNA      
Met-e (probe sequence AAA TTA TTG TGC CCC G) via Northern.  
 
qPCR of hLa precipitated mRNAs 
Crosslinking of RNA protein complexes was performed as described 166. Briefly, one 15cm plate 
of HEK293T cells was transfected with pEGFPC1-hLa 1-375, pEGFPC1 hLa 1-375 
K86A/T87A/K88A or the pEGFPC1 vector control and crosslinked with 1% formaldehyde at 
room temperature for 10 minutes.  The reaction was stopped with 0.25M glycine pH 7.0 for 5 
minutes at room temperature.  Cells were washed twice in 1X PBS followed by lysis in 1 mL RIPA 
 52 
buffer with DNase treatment (4U, 5 minutes at 37oC).  Immunoprecipitations were performed 
using anti-GFP and Protein G beads with three 500 uL washes in RIPA buffer then three 500 uL 
washes in PNK buffer (50 mM Tris-HCl pH 7.0, 5 mM EDTA, 10 mM DTT, 1% SDS) followed 
by reversal of crosslink by incubation at 70oC for 45 minutes.  RNA was Trizol extracted followed 
by isopropanol precipitation.  Input and eluted RNAs were converted to cDNA using BioRad 
iScript cDNA synthesis kit and assessed by quantitative real-time PCR using SensiFAST SYBR 
No-ROX Kit (Bioline) using the following settings:  Hot start @ 95oC for 5 minutes; (denaturation 
for 5 sec @ 95oC, annealing/extension @ 60oC for 10 sec) x 40 cycles.   Relative abundance was 
calculated as enrichment over empty vector normalized to input using the ΔΔCt method.  Primers 
used:  BiP Forward: GAAAGAAGGTTACCCATGCAGT, BiP Reverse:  
CAGGCCATAAGCAATAGCAGC; CCND1 Forward: 
CTCTCCAGAGTGATCAAGTGTGACCC, CCND1 Reverse: TGTGCAAGCCAGGTCCACC; 
5.8S rRNA Forward: TCTTAGCGGTGGATCACTCGGC, 5.8S rRNA Reverse: 
GCTCAGACAGGCGTAGCCC. Values presented represent mean enrichments over a minimum 
of three biological replicates. 
 
Polysome analysis 
Polysome analysis was performed as described 167.  Briefly, two 15cm dishes of transfected 
HEK293T cells were lysed 24 hours post transfection in hypotonic lysis buffer [5 mM Tris-HCl 
(pH 7.5), 2.5 mM MgCl2, 1.5 mM KCl, 100 µg/mL cycloheximide, 2 mM DTT, 0.5% Triton X-
100, and 0.5% sodium deoxycholate] and cell debris was removed by centrifugation.  20 A260nm of 
cell lysate was loaded over a 7 step 20-50% sucrose gradient prepared according to the method of 
Luthe 168 in 20 mM HEPES-KOH (pH 7.6), 100 mM KCl, 5 mM MgCl2 followed by centrifugation 
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at 30,000 rpm for 3 hours in a Beckman SW41 rotor.  Gradients were fractionated into 500 µL 
fractions of which 20 µL was separated by SDS-PAGE and blotted using the relevant antibodies.  
Anti-Rpl9 antibody was from Abcam (ab182556).   For puromycin treatment, cell lysates were 
treated with 25 µM puromycin for 15 minutes and cyclohexamide was omitted 169.  
 
CCND1 IRES luciferase reporter assay  
The CCND1 IRES was cloned as a cDNA from HeLa poly(A) purified RNA into the SalI-BamHI 
site of the pDL-N dual luciferase construct 170 and confirmed by sequencing.  This construct was 
then used as a template for a PCR reaction using primers that added an SP6 promoter upstream of 
the renilla 5' UTR and a 20A or 40A sequence after the firefly 3' UTR. The PCR product was used 
as a template for a SP6 RNA polymerase mediated in vitro transcription of capped mRNA using 
the SP6 mMESSAGE mMACHINE kit from Ambion as per manufacturer’s protocol. HEK 293T 
cells were plated in 6 well plates 18 hrs prior to transfection in antibiotic free media and transfected 
with 4ug plasmid DNA (pEGFPC1-hLa 70 and PABPC1-cmyc 165 or vector controls) and 
Lipofectamine 2000 as per the manufacturer’s instructions. 24 hours post transfection, cells were 
re-plated into 96 well plates and transfected with 150ng of mRNA. 24 hours post transfection 
lysates were measured using Dual-Luciferase Reporter Assay (Promega).  To test for reporter 
mRNA levels, qPCR of the firefly cistron was performed using the Qiagen one-step RT-PCR kit 
(Qiagen #210210) and TaqMan based primers, normalized to the U5 snRNA as measured by 
SYBR qPCR as described above.  Primers:  U5 snRNA For:  TGG TTT CTC TTC AGA TCG 
CAT AAA, U5 snRNA Rev: CCA AGG CAA GGC TCA AAA AAT; Firefly For:  GAC GAT 
GAC GCC GGT G, Firefly Rev: GAC TGG CGA CGT AAT CCA, Firefly TaqMan Probe:  /56-
FAM/CC GCC GTT G/ZEN/T TGT TTT GGA GCA C/3IABkFQ/.  TaqMan probe was from IDT.   
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2.4 Results 
 
La binds to poly(A) in a sequence specific and length dependent manner 
While La preference for terminal uridylates has previously been established, La binding to 
extended adenylate sequences has not been tested, despite the established association of La with 
cellular mRNAs in both yeast and humans cells 56,58,59,115,116.  To test La binding to polyadenylate 
sequences, we compared hLa binding to various RNA homopolymers using electromobility shift 
assay (EMSA; Figure 10, Supplementary Figure 1, Supplementary Table 1).  To better assess 
the nature of specificity of RNA binding in our analysis, we included one of two competitors in 
our EMSA analysis.  The first was a small hairpin with a single stranded 3' tail derived from a La 
target, the Hepatitis C IRES, as La has previously been demonstrated to bind to this RNA in a 
manner that relies on its secondary structure in the absence of sequence specificity 41.  The alternate 
competitor was a C10 homopolymer, which is not expected to form secondary structure.    
Using the hairpin-containing competitor (Figure 10), we found that hLa bound U10 with 
substantially higher apparent affinity than C10, G10 or A10, consistent with previous results 
demonstrating high affinity binding of La to terminal uridylates.  However, when the length of the 
homopolymers was increased to twenty nucleotides, the apparent affinity of hLa for A20 increased 
substantially. This increase in affinity was specific for adenylates, as C20 bound hLa with low 
affinity, similar to C10 (Figure 10A, B, Supplementary Figure 1).  We noted that G20 tended to 
dimerize, with the free RNA running as two bands (Supplementary Figure 1).  Interestingly, hLa 
shifted the G20 dimer with reasonably high affinity, while the single stranded G20 band had 
similarly poor affinity as the G10 homopolymer, reminiscent of previous work indicating binding 
of hLa to RNAs with secondary structure in the absence of sequence specificity 40,41.  
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We then compared hLa binding to U10 and A20 in the presence of C10 as a competitor to 
our previous result using the hairpin-containing competitor (Figure 10 C, D).  We found that the 
apparent affinity for the U10 substrate using C10 as a competitor was nearly identical to that when 
using the hairpin-containing competitor.  However, the apparent affinity for A20 increased when 
substituting C10 as a competitor, to the extent that the apparent Kd of hLa for A20 was only slightly 
lower than that of U10.  These data suggest that a) hLa binds A20 with high affinity in a manner 
that is length dependent and that discriminates adenylates from C or (single-stranded) G, and b) 
structured RNAs compete slightly better for A20 binding than single-stranded RNA, suggesting 
that some A20 contacts may partially overlap with contacts associated with structure dependent, 
UUU-3'OH independent binding 41.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 56 
 
 
 
 
 
Figure 10: Human La displays length dependent affinity for poly(A) 
Human La displays length dependent affinity for poly(A).  (A) Binding of recombinant human La 
for U10, U20, A10 and A20 was tested by electromobility shift assay (EMSA) using HepC hairpin 
RNA as competitor; gels for C10, C20, G10 and G20 provided in Supplementary Figure 1.  (B)  
Graphical representation of EMSA results.  (C)  EMSA of human La for U10 and A20 in the 
presence of C10 as competitor.  (D)  Graphical representation of binding curves comparing La 
affinity for U10 and A20 with C10 versus HepC hairpin competitors. 
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In order to better understand the potential overlap between the UUU-3'OH dependent 
binding mode and those contacts important for A20 binding, we performed direct competition 
experiments between uridylate and adenylate containing RNAs (Figure 11). We determined an 
amount of recombinant human La (2 µM) sufficient to achieve >95% binding of radiolabelled A20 
(NR lane, Figure 2.2A) or U20 (NR lane, Figure 2.2B) in the absence of competitor, then added 
this amount of protein to pre-mixed radiolabelled and cold RNAs containing increasing 
concentrations of cold competing RNA substrates to determine their propensities to compete our 
radiolabelled RNAs from hLa.  In order to demonstrate a successful competition reaction, we 
performed competitions with the identical cold U20 or A20 RNAs (Figure 11 A & B, right hand 
sides).  These experiments revealed that at this concentration, La-RNA binding was occurring in 
two stages: in the absence of competitor (NR), La protein at 2 µM supershifts U20 and A20 (i.e. 
greater than one La per RNA, as has been described previously at higher concentrations of La 
(reviewed in 49).  This supershift would then shift down to a 1:1 La-RNA RNP with increasing like 
competitor, as the cold RNAs titrated hLa causing a supershift away from the radiolabelled 
substrates. (Figure 11 A & B, right hand sides; 1:1 La-RNA indicated as “1”, La-RNA supershifts 
as “2”).   We found that addition of cold competing U10 to radiolabelled A20 titrated La resulting 
in a supershift away from A20, causing a clear mobility shift to the 1:1 La-A20 species at lower 
concentration of competitor (Figure 11A, left hand side, marked with “*”).  However, increasing 
addition of U10 did not result in a release of A20 from the hLa-A20 RNP even at the highest 
concentration of U10 competitor tested (32 µM).  These data indicate that despite U10 being active 
in our assay (addition of U10 titrated La that caused a supershift away from A20) it did not result 
in release of A20 from the A20:hLa RNP, suggesting that the U10 competes poorly for A20 and 
that their binding modes are at least partially distinct.  
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We considered that the La RNP in the presence of both A20 and U10 could be a double 
stranded RNA duplex, and that the La RNP observed with increasing competitor could be the result 
of La binding to double stranded RNA.  To test this, we added increasing concentration of A10 to 
the hLa:U20 RNP (Figure 11B, left panel), as U20:A10 should have a similar propensity to form 
a duplex as A20:U10.  Unlike the A20:U10 competition, however, A10 had no effect on the 
hLa:U20 RNP, as measured by the persistence of supershift with increasing concentration of A10, 
consistent with our previous data (Figure 10) showing low affinity for A10.  In sum, these data 
are consistent with a relatively poor ability of adenylates to compete with uridylates on hLa and at 
least partially distinct poly(A) and UUU-3'OH binding modes.  
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Figure 11: Uridylate containing RNAs compete poorly for poly(A) binding to hLa 
Sufficient recombinant human La was added (2 µM) to radiolabelled A20 to achieve >95% binding 
(NR: No cold RNA added) and increasing concentrations of various cold RNAs were added to 
assess their ability to displace A20 from hLa.  (A)  Comparison of U10 (left-hand series) and A20 
(right-hand series) for radiolabelled A20 binding.  (B) Comparison of A10 (left-hand series) and 
U20 (right-hand series) for radiolabelled U20 binding.    NP: No recombinant hLa Protein added 
(i.e. free radiolabelled A20 or U20). “1”:  indicative of 1:1 La-RNA complex; “2”: indicative of 
multimeric La-RNA complex.  * (asterisk):  New RNP formed between La and A20 with addition 
of U10. 
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The winged-helix face of the La motif functions in adenylate binding 
High resolution La module/UUU-3'OH co-crystal structures have previously identified the 
regions of La required for uridylate recognition 62,63, and these surprisingly revealed that the 
expected nucleic acid binding surface of the LAM (the winged helix face) does not make any 
contacts to the UUU-3'OH motif (Figure 12A).  To further investigate potential differences 
between the UUU-3'OH and A20 binding modes, we compared U10 versus A20 binding across 
some La mutants (Figure 12). We tested a mutant we have previously demonstrated as having 
significantly compromised affinity for terminal uridylates 86 by virtue of mutations to three amino 
acids critical for UUU-3'OH binding (hLa Q20A/Y23A/D33R) for its differential ability to bind 
U10 and A20.  Consistent with our competition data arguing for at least partially distinct U10 and 
A20 binding modes, this mutant had nearly negligible U10 binding yet still bound A20.  We 
observed a slight decrease in A20 affinity relative to wild-type, (Figure 12B, C), consistent with 
either a slight folding defect for this variant, as has been noted previously 40, or the possibility that 
amino acids critical for UUU-3'OH binding may also play a role in adenylate binding.  
Nevertheless, the near complete loss of binding of this mutant to U10 relative to the continued 
binding to A20 are consistent with the uridylate and adenylate RNA binding modes still being 
substantially distinct.  
We considered the possibility that the expected winged helix-fold nucleic acid interaction 
surface of the La motif might comprise one of the regions important for A20 recognition, as this 
region has not yet been demonstrated to engage an RNA ligand.  We therefore tested several sets 
of point mutants around the La motif for their differential ability to bind U10 versus A20.  The 
hLa mutant R32A/K34A/K37A, whose mutated amino acids map to neither the winged-helix face 
nor the UUU-3'OH recognition site, had no defect in binding either substrate, while the hLa 
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F65A/N66A/E70A and E70A/K74A/K76A mutants, whose mutations map to the canonical 
winged-helix recognition helix of the La motif, showed slightly impaired binding to both U10 and 
A20, suggesting they may be misfolded (data not shown).  The hLa mutant K86A/T87A/K88A 
comprises mutations to the first “wing” of the La motif’s winged helix fold; while this mutant 
bound U10 nearly indiscernibly from wild-type, it had a more substantial drop in affinity for the 
A20 substrate, as well as a more gradual binding curve (Figure 12E), suggesting the possible loss 
of one of several cooperative binding sites.  These data suggest these amino acids contribute to the 
affinity of La for poly(A) but not UUU-3'OH, even if this mutant still contains other surfaces that 
contribute to poly(A) binding, consistent with our observed length dependence of the adenylate 
binding mode. 
To further test these ideas, we compared U10 and A20 binding across a series of hLa 
deletion mutants (Supplementary Figure 2).  Consistent with previous work indicating that the 
LAM and RRM1 form a single binding pocket for UUU-3'OH, deletion of the LAM (hLa dLAM) 
or RRM1 (hLa dRRM1) resulted in near complete loss of U10 binding.  However, each of these 
mutants were still able to completely shift the A20 substrate, albeit at significantly higher 
concentrations than the wild-type protein. Deletion of RRM2 and amino acids C-terminal to this 
(1-235) had no effect on U10 binding, as expected, while A20 binding was slightly enhanced, 
suggesting that contacts that contribute to A20 binding are contained within the La module and 
the unstructured region between RRM1 and RRM2.  In sum, our results suggest that while the 
binding of La to UUU-3'OH is an event that relies integrally on the presence of both the LAM and 
RRM1 forming a single binding site, the adenylate binding mode uses sites on the LAM and RRM1 
that function more additively and that cooperate for high-affinity binding. 
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Figure 12: The winged-helix face of the La motif is involved in adenylate binding 
(A)  Structure of La motif 63 with uridylate binding amino acids labeled in red, UUU-3'OH RNA 
in cyan, winged helix face of La motif in yellow and mutated amino acids of winged-helix face in 
green.  (B)  EMSAs of hLa Q20A/Y23A/D33R binding to U10 and A20.  (C) Graphical 
representation of hLa and hLa Q20A/Y23A/D33R bound to U10 and A20.  (D)  EMSAs of hLa 
K86A/T87A/K88A binding to U10 and A20.  (E) Graphical representation of hLa and hLa 
K86A/T87A/K88A bound to U10 and A20.  
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 Cytoplasmic La binds directly to poly(A) in human cells 
 
Human La is largely nuclear where it engages RNA polymerase III transcripts, but also 
shuttles to the cytoplasm where it can accumulate during conditions of cellular stress or viral 
infection 89,109,171,172.  To test whether hLa can directly engage poly(A) tails in human cells, we 
performed cross-linking immunoprecipitation (CLIP), which included a limited RNase I digestion 
step in order to degrade RNA not in direct contact to hLa (Figure 13A).  To differentiate hLa RNA 
binding profiles in the nucleus versus the cytoplasm, we transfected GFP-tagged wild-type and 
nuclear localization signal deleted (ΔNLS 173,174; hLa 1-375; localization of constructs in 
Supplementary Figure 3) hLa constructs into HEK293T cells.  We also tested our point mutant 
with compromised A20 binding (K86A/T87A/K88A) in both the full length (nuclear) and 1-375 
(cytoplasmic) contexts, as well as a myc-tagged cytoplasmic PABP construct as a poly(A) binding 
positive control. 
We observed that PABP was highly effective in pulling down a range of poly(A) RNA 
lengths relative to the non-immune sera control, consistent with the heterogeneous length of 
poly(A) tails observed in the cytoplasm.  However, PABP was incapable of pulling down a La 
RNA polymerase III substrate previously demonstrated to be an unusually stable and a very highly 
abundant hLa target, pre-tRNA Met-e 175,176, as expected.  We found that the cytoplasmic GFP-
hLa 1-375 immunoprecipitated poly(A) RNA of similar size range as PABP, and to a substantially 
greater extent than our nuclear GFP-hLa construct, relative to the poly(A) independent hLa target 
pre-tRNA Met-e.  However, the GFP-hLa 1-375 K86A/T87A/K88A mutant was substantially 
impaired in poly(A) immunoprecipitation compared to GFP-hLa 1-375, despite still pulling down 
pre-tRNA Met-e.  These data are consistent with hLa binding to poly(A) directly in the cytoplasm 
and further support the importance of the LAM winged helix in binding poly(A) over UUU-3'OH 
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containing substrates.  To test the nature of this interaction further, we repeated the CLIP using 
excess RNase T1, which cuts specifically at “G” residues, as this should separate RNA upstream 
of the poly(A) tail but leave the leave poly(A) tail intact.  We found that GFP-hLa 1-375 still 
immunoprecipitated poly(A) signal similar to PABP (Figure 13A, right-hand side), also consistent 
with hLa 1-375 making contact to the poly(A) tail directly.    
To further assess the importance of the winged helix face of the La motif in the binding of 
previously characterized La mRNA targets, we immunoprecipitated GFP-hLa 1-375 and GFP-hLa 
1-375 K86A/T87A/K88A associated transcripts in the context of reversible formaldehyde 
crosslink and determined their relative abundance using quantitative RT-PCR (Figure 13B).  We 
observed a significant enrichment of GFP-hLa 1-375 with the cyclin D1 and BiP mRNA transcripts 
relative to the GFP alone control, as expected.   However, the ability of GFP-hLa 1-375 to 
immunoprecipitate these mRNAs was substantially impaired in the context of the 
K86A/T87A/K88A mutations, and was more similar to the vector control, in agreement with our 
UV-CLIP data (Figure 13A).  As a negative control, we observed no enrichment for the 5.8S 
rRNA (which lacks a poly(A) tail) relative to the vector control.  Thus our immunoprecipitation 
data suggest that cytoplasmic La binds mRNAs in cells at least in part via the poly(A) tail, and that 
the winged-helix face of the La motif contributes to this binding, similar to our data in vitro. 
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Figure legend on next page. 
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Figure 13: Human La binds to poly(A) in human cells 
 
(A) Crosslinking immunoprecipitation of transfected myc-PABP and GFP-hLa or GFP-hLa 
mutants in HEK293T cells. Left: limiting digestion with RNase I; right:  Digestion with RNase 
T1.  IP:  immunoprecipitation. Presence of poly(A) or pre-tRNA Met-e in immunoprecipitated 
RNPs was assessed by Northern blot. Bottom: Western blot confirming transfection of myc-PABP 
or GFP-hLa.  (B) Co-immunoprecipitation of cyclin D (CCND1) mRNA, BiP mRNA or 5.8S 
rRNA with hLa 1-375 versus hLa 1-375 GFP-hLa K86A/T87A/K88A relative to GFP vector only 
control as measured by qPCR.  Error bars correspond to standard error of the mean, asterisks 
highlight statistically significant changes (*= P-value < 0.05; *** = P-value <0.001 two-tailed 
student t-test).    
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The poly(A) binding mode contributes to La entry into polysomes 
La proteins have been implicated in the translation of several mRNAs and have been 
previously demonstrated to enter into polysomes 177.  We therefore hypothesized that the adenylate 
binding mode could play an important role in the capacity of La to enter polysomes via contacts 
to the poly(A) tail.  We transfected GFP-hLa and the cytoplasmic GFP-hLa 1-375 into HEK293T 
cells and performed polysome fractionation followed by Western blot against GFP (Figure 14).  
We indeed observed entry of GFP-hLa 1-375, and to a lesser extent GFP-hLa, into polysomal 
fractions, confirming that hLa (and predominantly cytoplasmic hLa) associates with translating 
polysomes, consistent with previous work 177.  To test the importance of the hypothesized poly(A) 
binding mode, we compared these results to the entry of GFP-hLa K86A/T87A/K88A and GFP-
hLa 1-375 K86A/T87A/K88A into polysomal fractions.  We observed a substantial decrease in 
the ability of these mutants to enter into polysomes, and instead observed them in abundance 
exclusively at the top of the polysome gradient.  Addition of puromycin to GFP-hLa 1-375 
transfected samples resulted in a collapse of polysomes and a concomitant loss of GFP-hLa 1-375 
in the higher molecular weight fractions, confirming that GFP-hLa 1-375 is indeed associating 
with polysomes.   These data are consistent with the winged-helix face of the La motif previously 
identified as a component of an hLa poly(A) binding mode playing an important role in La 
engagement of translating mRNAs. 
 
 
 
 
 
 69 
 
 
 
 
 
 
Figure 14: The poly(A) binding mode promotes hLa entry into polysomes  
Top:  Trace of ribosomes/polysomes fractionated from HEK293T cells transfected with indicated 
constructs or treated with puromycin.   Bottom:  Western blots versus Rpl9 and GFP-hLa, GFP 
hLa 1-375 and indicated mutants, as well as a puromycin treated control for GFP hLa 1-375. 
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La binding to poly(A) in cap-dependent and cap-independent translation 
La function has been associated in the enhancement of cap-independent translation, and 
has been associated with either the enhancement or inhibition of cap-dependent translation 
depending on the identity of the transcript.  To further test the importance of the poly(A) dependent 
binding mode in translation, we cloned the La-associated IRES from the human cyclin D (CCND1) 
gene into a dual-luciferase reporter construct, similar to what has been described previously 58, and 
used this to generate SP6 transcription templates from which we made capped mRNAs for direct 
transfection into HEK293T cells (Figure 15A).  This experimental design allowed us to control 
the poly(A) tail length of our transfected messages, which we set at twenty or forty adenosines 
(20A or 40A).  These reporter mRNAs were transfected into cells that had been transfected twenty-
four hours prior with plasmids encoding GFP-hLa (nuclear), GFP-hLa 1-375 (cytoplasmic) or the 
poly(A) binding impaired versions of these (GFP-hLa K86A/T87A/K88A or GFP-hLa 1-375 
K86A/T87A/K88A), or the GFP vector control, and the effects on cap-dependent and cap-
independent translation were assessed.  We observed that overexpression of GFP-hLa 1-375 had 
a substantially greater positive effect on both cap-dependent (renilla) and cap-independent 
translation (firefly) than GFP-hLa, consistent with cytoplasmic hLa promoting the translation 
and/or stability of our transfected bicistronic reporter mRNAs (Figure 15B).  Notably, GFP-hLa 
1-375 K86A/T87A/K88A had a significantly lesser positive effect on translation of both the renilla 
and firefly cistrons than GFP-hLa 1-375 despite equal levels of GFP-hLa 1-375 
K86A/T87A/K88A expression (Figure 15A), consistent with the poly(A) associated binding mode 
functioning in La enhancement of expression from the reporter.   qPCR of the reporter mRNAs 
eight hours post-transfection revealed that increased expression from the reporter mRNAs was not 
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due to enhanced mRNA stability in the context of GFP-hLa 1-375 transfected relative to GFP or 
GFP 1-375 K86A/T87A/K88A transfected cells (Figure 15C). 
We then attempted to further design an experiment that might uncouple the potential 
positive effects of La on translation from those on mRNA stability. While testing for effects on 
the expression of mRNAs +/- a poly(A) tail in cells is challenging due to the anticipated 
degradation of messages lacking a poly(A) tail, we hypothesized that if La promotes translation at 
least in part through engagement of the poly(A) tail, then this might occur in competition with 
cytoplasmic PABP.  We therefore repeated our GFP-hLa and GFP-hLa 1-375 overexpression 
experiments in the presence and absence of overexpressed myc-PABPC1, bearing in mind that 
both hLa and PABPC1 have an apparent minimum poly(A) tail binding length: ~ 20A for hLa (this 
work) and 12-25 nt for PABPC1 178.  Co-transfection of myc-PABPC1 resulted in further enhanced 
expression from the renilla reporter relative to hLa 1-375 for the 40A tailed construct but not the 
20A tailed construct (Figure 15D), consistent with both PABPC1 and hLa 1-375 promoting cap-
dependent translation on this reporter but with the 20A construct possibly being too short for these 
factors to act additively. Most importantly for this work, co-transfection of myc-PABPC1 had the 
opposite effect on cap-independent translation, significantly mitigating GFP-hLa 1-375 associated 
enhancement of firefly expression for the 20A construct (Figure 15D), as well as the firefly/renilla 
ratio for both the 20A and 40A constructs (Figure 15E).  Since lowering the ratio of cap-
independent translation to cap-dependent translation in the presence of excess PABP (Figure 15E) 
is not expected to result from altered stability of a bicistronic mRNA, this result is consistent with 
La-dependent enhancement of expression from the IRES reporter being due, at least partially, to 
La promoting translation at the IRES through contacts to the poly(A) tail.  While the specific nature 
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by which PABP and hLa functionally interact in this system remains to be determined, these data 
further corroborate the link between La-associated function in translation and the poly(A) tail.    
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Figure legend on next page. 
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Figure 15: The human La poly(A) binding mode contributes to La function in translation 
(A) Left:  Schematic of bicistronic reporter construct used for direct transfection into HEK293T 
cells.  Right:  Western blots of transfected myc-PABP, GFP-hLa, GFP-hLa 1-375 or 
K86A/T87A/K88A mutants of these.  GAPDH shown as loading control.  (B)  Relative expression 
of cap-dependent (left; renilla) and cap-independent (right; firefly) reporter genes in the presence 
of overexpressed GFP-hLa, GFP-hLa 1-375 or the K86A/T87A/K88A mutants on the 20A or 40A 
tailed mRNA reporter constructs normalized to level expression in GFP vector control.  ** = 
P<0.001.  (C)  Enhanced expression from bicistronic reporter mRNAs upon co-expression of GFP-
hLa 1-375 is not due to enhanced reporter mRNA stability. Total RNA was isolated and levels of 
transfected 20A or 40A bicistronic reporters were assessed by qPCR eight hours post-transfection 
in cells that had been previously transfected by indicated GFP or GFP-hLa 1-375 constructs. 
Reporter mRNA levels are provided relative to amounts in the GFP-vector transfected cells after 
normalization for total RNA abundance via qPCR for the U5 snRNA. (D) Effect of overexpression 
of myc-PABP on the GFP-hLa and GFP-hLa 1-375 associated expression of cap-dependent (left, 
renilla) and cap-independent (right, firefly), normalized to the expression levels in the context of 
the GFP vector control +/- overexpression of myc-PABP.  ** = P<0.01.  (E)  Ratios of 
renilla/luciferase expression in the context of GFP-hLa or GFP-hLa 1-375 expression +/- the 
expression of myc-PABP. *** = P<0.001.  Error bars:  SEM. 
 
 76 
2.5 Discussion 
 
Human La binds to poly(A) sequences in vitro and in human cells 
In this work, we propose that human La binds adenylate sequences with high affinity, and 
that this binding mode represents at least one important way that La contacts coding RNAs in the 
cytoplasm. La proteins have been associated extensively with the engagement of mRNAs with 
consequent effects on their translation, but until this work, it was previously hypothesized that La 
engages such coding transcripts exclusively via non-specific recognition of structured RNA 
elements.  In this work, we demonstrate that human La has higher affinity for adenylate containing 
sequences compared to poly(C) or single stranded poly(G) in a length dependent manner.  We 
show that point-mutation of the winged-helix face of the La motif results in decreased binding to 
A20 but not a UUU-3'OH containing RNA, consistent with the adenylate and UUU-3'OH binding 
modes being at least partially distinct.  Using UV-CLIP, we demonstrate that cytoplasmic La 
contacts poly(A) tails directly in a manner analogous to PABP in tissue culture cells, then 
demonstrate that the adenylate binding mode contributes to immunoprecipitation of previously 
identified La-mRNA targets, La entry in to polysomes, and La function in translation using a 
bicistronic cap-dependent/IRES reporter containing defined adenylate lengths.  While the 
complete mechanism by which La binds to poly(A) tail and its consequent functional overlap with 
the role of PABP have not yet been fully explored, our data are consistent with La binding to 
poly(A) acting as an important determinant for La function in mRNA expression in the cytoplasm.  
    
La function in cap-independent and cap-dependent translation 
In the nucleus, La proteins are recruited to nascent RNA polymerase III transcripts, such 
as pre-tRNAs, via sequence specific recognition of UUU-3'OH 54,79.  La then assists these targets 
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attain their native fold via RNA chaperone activity prior to UUU-3'OH processing and removal 
40,86,179.  In the cytoplasm, La was identified as the first cellular factor important for the 
enhancement of IRES dependent, cap-independent translation, a theme that has since recurred for 
a number of viral and cellular IRES containing transcripts, leading to hypotheses that La may also 
function as an RNA chaperone for these 99.   For IRES containing cellular mRNAs that contain a 
poly(A) tail, our data are consistent with a model in which La recognition of poly(A) may direct 
La-associated RNA chaperone activity to its mRNA targets in an analogous manner to how UUU-
3'OH does the same for nascent RNA polymerase III transcripts.  In such a scenario, hLa might 
remain bound at the poly(A) tail and function as an RNA chaperone by looping the RNA between 
the poly(A) tail and the 5' UTR/IRES, or hLa could first be recruited to the mRNA via the poly(A) 
tail and then translocate to these sites.  Previous work noting a number of potential RNA binding 
sites on La support the idea that La may be able to engage the poly(A) tail as well as and other 
regions of an mRNA simultaneously 40,41,153,154,180, but this has yet to be demonstrated formally.   
La function in cap-dependent translation appears to be more complex, as various studies 
have proposed either an activating or inhibitory role for La at the 5' cap.  It has been previously 
noted that mRNAs whose cap-dependent expression is inhibited by La tend to have short 5' UTRs, 
such as 5' TOPs, while those that tend to be enhanced often have complex 5' UTRs that may rely 
on La-dependent RNA remodeling for optimal translation, similar to the role proposed for La at 
IRESs 68. One factor whose role in the complex interplay coordinating expression at the cap is 
becoming increasingly appreciated is the La-related protein LARP1. Similar to La, human LARP1 
(hLARP1) has also been hypothesized to bind to poly(A) directly 123, as well as via contacts with 
PABP 162, and reminiscent of La function on coding transcripts, has been associated with both the 
enhancement and inhibition of cap-dependent translation 124,125.  Very recently, a structural domain 
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unique to LARP1 family members and lacking in genuine La proteins, the DM15 region, has been 
demonstrated to bind the 7-methylguanosine cap in the context of a cytosine at +1, as is commonly 
observed in 5' TOP sequences 73,181.  These insights on LARP1 function in the expression from the 
cap have recently been expanded by work showing that LARP1 can be phosphorylated directly by 
mTORC1 and Akt to switch from an inhibitory to an activating role 182, as well other work 
demonstrating a role for hLARP1 in controlling the stability of 5' TOP mRNAs on 40S ribosomes 
independent of translation 183, which is reminiscent of other work linking LARP1 family members 
and mRNA transcript stability 123,184,185.  Future work will be required to deconvolute the complex 
interplay of LARP1, PABP and La at the poly(A) tail and the various effects of these on mRNA 
translation and degradation.   
 
Poly(A) binding in the LAM superfamily 
While La proteins have documented functions for both RNA polymerase III and coding 
transcripts, each of the various LARP families target only one of these classes: the LARP7 family 
members hLARP7 and p65 engage RNA polymerase III transcripts, also using a UUU-3'OH 
dependent RNA binding mode, and the LARP1, LARP4 and LARP6 families are associated with 
mRNA translation (reviewed in 50,65) .  While members from the LARP1, LARP4 and LARP6 
families have been documented to interact with PABP 121,130,132,163, several LARPs have also been 
hypothesized to engage poly(A) directly, with human LARP4 and LARP1 demonstrating affinity 
for adenylates in a length dependent manner, similar to La 123,163.  Consistent with our findings, 
one study that screened for factors that could be affinity purified in a poly(A) dependent manner 
identified not only hLARP1, but also human La 123. Future structural work will be very helpful in 
determining the precise contacts between La and poly(A) and whether LARPs that engage poly(A) 
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use the same LAM surface as in hLa, given the high conservation of the La motif between the La 
and La-related proteins. 
Our data suggest that the hLa LAM and RRM domains are important for both the UUU-
3'OH and poly(A) binding modes, but that the respective RNA binding surfaces on these domains 
do not entirely overlap.  In La proteins, the linker region bridging the LAM and RRM domains is 
flexible in the RNA-free form, but for those LARPs that have been tested, this appears to not be 
the case 63.  Notably, the observation that this linker region is much shorter in La modules of the 
LARP4 family and in hLARP6 42,139, as well as the observation of LAM-RRM interdomain 
contacts in the hLARP7 protein 186, has led to the hypothesis that unlike genuine La, the orientation 
of the linker region in the LARPs is fixed and may constitute an important RNA binding 
determinant 139.   It will thus be fascinating to investigate whether the flexibility observed between 
the LAM and RRM of hLa may relate to its capacity to accommodate both the poly(A) and UUU-
3'OH binding modes, while the fixation of the orientation between the LAM and RRM in the 
LARPs is an outcome of their specialization for a single class of target.  
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2.7 Supplementary Figures  
 
 
 
 
Supplementary Figure 1: Binding of hLa to C and G homopolymers 
 
Binding of wild-type hLa 1-408 to C and G homopolymers in the presence of HepC/ssRNA 
competitor 
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Supplementary Figure 2: Binding of hLa deletion variants to U10 and A20 
 
Binding of hLa deletion variants to U10 and A20 in the presence of hepC/ssRNA competitor 
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Supplementary Figure 3: Localization of GFP-hLa variants 
Localization of GFP-hLa and GFP-hLa 1-375 variants in HEK293T cells 
 
 
 
 
DAPI GFP Merge 
hLa	 
full-length 
hLa	1-375 
hLa	1-375 
K86A/T87A/K88A 
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Supplementary Table 1: Dissociation constants and relative dissociation constants for 
tested La variants 
Dissociation constants (Kds, in µM) and relative dissociation constants (Krel) for tested La variants. 
Kd U10 and Kd A20: measured dissociation constants for proteins for U10 and A20 substrate in 
the presence of HepC/ssRNA competitor, respectively. Krel vs hLa U10 or A20: Kd of indicated 
mutant for U10 or A20 relative to that for wild-type hLa. Krel A20/ Krel U10: fold change in binding 
to A20 relative to fold change in binding to U10. 
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3.1 Summary  
 
Although the human La protein is mostly associated with the processing of nascent RNA 
polymerase III transcripts, La proteins are also hypothesized to promote cap-independent 
translation of several cellular and viral coding RNAs, but the context and mechanism by which La 
binds to coding RNAs is yet to be established. During conditions of viral infection, cellular stress, 
and tumor progression, the predominantly nuclear hLa protein has been shown to translocate to 
the cytoplasm where it functions as an (IRES) trans-acting factor (ITAF), controlling cap-
independent translation initiation of several cellular IRES-containing mRNAs including BiP, 
Laminin B1, NrF2, XIAP and CCND1. These La associated cytoplasmic substrates are often 
involved in cell cycle regulation, apoptosis, tumorigenesis, and stress responses, signifying an 
important role for La during cellular stress conditions. Although a mechanism for nuclear-
cytoplasmic shuttling of La has been described for polioviral infection, the mechanism for 
shuttling of La during conditions of cellular stress is yet to be determined. Here, we show that 
cellular stress induced by clotrimazole, a mitochondrial inhibitor and inducer of stress granules, 
causes translocation of hLa from the nucleus to the cytoplasm. Using polysome analysis coupled 
with qPCR, we show that this translocation to the cytoplasm is concurrent with increased 
association of La with actively translating messages. Using iCLIP, we identify novel substrates of 
La that contain IRES elements and are translated during cellular stress. Taken together, our data 
show that hLa is trafficked into the cytoplasm in response to cellular stress to associate with 
translating messages during suboptimal cellular conditions.  
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3.2 Introduction  
Gene regulation in eukaryotic cells is an intricate process where the expression levels of 
proteins are regulated by the efficiency of mRNA translation187. As the ability of cells to maintain 
active translation in response to cellular stress is vital for its survival, cells have evolved and 
adopted various mechanisms to adapt and overcome cellular stress.  The well characterized cap-
dependent translation mode relies on the recruitment of the small ribosomal subunit to the 5' 7-
methyl guanine cap to commence scanning of the transcript until the initiator methionine codon 
has been identified. This is followed by the recruitment of the large ribosomal subunit to begin 
translation of the message188. In addition to the general recognition of the 5' cap, the ribosome can 
also initiate translation via an internal ribosome entry site (IRES) in a process termed cap 
independent translation. Internal ribosome entry sites were originally found in picornaviruses and 
are believed to have evolved for the purpose of recruiting the ribosome to initiate translation of 
uncapped viral mRNAs 189,190.  
In addition to viruses, IRES elements have been identified in the 5' UTR of a subset of 
cellular mRNAs including Nrf2191, myc 192,193, XIAP 108, CCND1 194, and BiP 195. Sequence and 
structural comparison between cellular IRESs indicate very little conservation and a common 
mechanism by which they function has not yet been determined; however, it is predicted that these 
cellular IRESs have evolved in order to maintain and promote protein synthesis during suboptimal 
cellular conditions where cap-dependent translation has been compromised such as mitosis, 
oxidative stress, apoptosis, mitochondrial stress, heat shock, and osmotic shock 196. Although very 
little is known about how mRNAs are translated under cellular stress, there is increasing evidence 
that cellular mRNAs containing IRES elements in their 5' UTR can escape recruitment into stress 
granules and are actively translated even when cap dependent translation is hindered 87,105,106. 
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Stress granules are dense aggregations composed of mRNAs and components of the cap-dependent 
translation machinery formed in cells undergoing a multitude of external stresses, and are 
associated with a general shift from cap-dependent to cap-independent translation. These 
membrane-less foci are hypothesized to protect stalled RNP complexes such that they can reenter 
into polysomes when cells return to homeostasis 197.  
While cap-dependent translation is regulated by several eukaryotic translation initiation 
factors, IRES elements not only require initiation factors, but also rely on IRES trans-acting factors 
(ITAFs) 198,199. While the exact function of these ITAFs is not yet fully understood, it is 
hypothesized that ITAFs function as RNA chaperones, assisting in inducing conformational 
change of the IRES to make the start codon accessible for the ribosome 87,92,139. ITAF requirements 
can vary for each IRES and these proteins often undergo various modifications including 
phosphorylation, increased protein expression, and nuclear-cytoplasmic shuttling 200,201. The 
human La protein was the first ITAF to be characterized and modification of La, specifically 
nuclear-cytoplasmic shuttling and changes in phosphorylation, has been observed further 
signifying a role for this protein in regulating IRES-mediated translation during cellular stress 158.   
Since its discovery, La has been linked to the translation from the IRESs of several viral 
RNAs including poliovirus, Hepatitis C virus, and encephalomyocarditis virus 57,158,176. Emerging 
studies have linked the La autoantigen to the IRES of numerous stress associated messages 
including the extracellular matrix signaling factor laminin B1, the X-linked inhibitor of apoptosis 
protein (XIAP), the stress associated ER chaperone protein BiP, the cell cycle regulator CCND1, 
and the master regulator of oxidative stress and transcription factor Nrf2 56,58,108,109,115. 
Additionally, La has been implicated in cancer progression, malignant epithelial to mesenchymal 
transition (EMT), and BCR/ABL associated leukomogenesis through its association with the IRES 
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containing cyclin D1 and laminin B1 mRNAs and the upstream open reading frame (uORF) 
containing MDM2 mRNA 58,115,116. 
La proteins are abundantly found in nearly all eukaryotes and function in facilitating the 
processing of RNA polymerase III transcripts42. First identified in patients suffering from systemic 
lupus erythematosus and Sjögren’s syndrome, the predominantly nuclear human La protein is most 
associated with the processing of nascent precursor transcripts via sequence specific recognition 
of the UUU-3'OH trailer along with the uridylate-tailed adenoviral VA RNA and the Epstein-Barr 
virus encoded EBER RNAs45,54,55,76,79,148–151. During conditions of viral infection, cellular stress, 
and tumor progression, hLa has been shown to translocate to the cytoplasm controlling cap-
independent translation initiation of several cellular IRES-containing mRNAs, although the 
mechanism and the context is not yet fully understood 109–111.  
In this study, we aimed to further characterize the context and mechanism by which La 
associates with these stress associated messages and aim to identify novel RNA substrates of La 
under normal and stress conditions. Given the previous association of La with coding transcripts 
that contain IRESs and uORFs that are upregulated during cellular stress, we considered whether 
La may be recruited to the cytoplasm to assist in translation of messages that escape recruitment 
into stress granules. To observe hLa relocalization in the presence of stress granules, we treated 
cells with clotrimazole, a well-characterized inducer of stress granules and inhibitor mitochondrial 
function. Using immunofluorescence, we show that induction of stress using clotrimazole results 
in a gradual shift in the localization of the La/SSB protein from the nucleus to the cytoplasm; 
however, La is not recruited into stress granules. Using polysome analysis coupled with qPCR, we 
show that several previously identified La associated messages that contain IRES elements are 
dependent on La for translation during cellular stress. Using iCLIP, we have identified novel 
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substrates of La and mRNAs that are upregulated during clotrimazole induced cellular stress. 
Interestingly, many of our novel La substrates contain previously established IRES elements in 
their 5' UTR. Using qPCR analysis, we show that these messages are not only upregulated during 
cellular stress, but are also dependent on La for optimal translation during suboptimal cellular 
conditions. Taken together, our data show that hLa is trafficked into the cytoplasm in response to 
clotrimazole induced cellular stress to associate with messages that continue to translate during 
compromised cellular conditions and rely on alternate mechanisms to promote translation.  
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3.3 Materials and Methods 
Drug Administration and Immunofluorescence 
 
HEK293T, U2OS, and HeLa cells from ATCC were grown in DMEM supplemented with 10% 
fetal bovine serum (FBS). Cells were stressed with 20uM clotrimazole in serum free media for the 
mentioned duration. Unstressed cells were mock treated with DMSO. 
Immunofluorescence was performed as described in Kedersha and Anderson 197. 12-18 hours prior 
to administration of stress, cells were plated on sterile coverslips at ~70% confluency. Following 
drug treatment, cells were washed once with PBS and immediately fixed with 4% 
paraformaldehyde for 20 minutes at room temperature. After washing twice with PBS, cells were 
permeabilized with 0.1% Triton X-100 in PBS for 10 minutes at room temperature. Cells were 
then washed twice with PBS and then blocked with blocking solution (1% BSA + 0.02% sodium 
azide in PBS) for 1 hour at room temperature. Cells were incubated with primary antibodies 
overnight at 4oC. Primary antibodies used were human anti-SSB (“GO” 1:500) and rabbit anti-
eIF4G (SantaCruz sc11373 1:250). After primary incubation, cells were washed twice with PBS 
and incubated with the appropriate secondary antibody for 1 hour at room temperature. Secondary 
antibodies used were goat anti-human AF546 (Lifetech A21089 1:500) and goat anti-rabbit AF488 
(Invitrogen A11008 1:500). Cells were washed twice with PBS, mounted using Vectashield 
(Vector Laboratories H-1200), and viewed under a Zeiss LSM700 Confocal Microscope.  
 
Transfection and Polysome Analysis  
 
All cells were cultured in complete DMEM plus 10% fetal bovine serum. For polysome 
analysis, cells were grown in 15cm dishes and transfected at ~70% confluency. 1 h before 
transfection, DMEM was replaced by OPTI-MEM. Plasmid DNA (10ug) and siRNAs (final 
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concentration of 100 nM) were transfected using Lipofectamine (Invitrogen). Cells were 
collected 48 hours post transfection.  
Polysome analysis was performed as described by Dowling R, 2007 202. Stressed cells were subject 
to 20uM clotrimazole in serum free media for indicated times before being lysed in hypotonic lysis 
buffer [5 mM Tris -HCl (pH 7.5), 2.5 mM MgCl2, 1.5 mM KCl, 100 µg/mL cycloheximide, 2 mM 
DTT, 0.5% Triton X-100, and 0.5% sodium deoxycholate]. Cell debris was removed by 
centrifugation. 20 A260nm of cell lysate was loaded over a 20-50% sucrose gradient made in 20 
mM HEPES-KOH (pH 7.6), 100 mM KCl, 5 mM MgCl2 followed by centrifugation at 30,000 
rpm for 3 hours in a Beckman SW41 rotor. Gradients were fractionated into fifteen 500 µL 
fractions, TCA precipitated, separated by SDS-PAGE, and blotted using the relevant antibodies 
[Anti-La SSB (Abcam 75927), Anti-PABP (Abcam 21060), Anti-Rpl9 (Abcam 182556), and anti-
GFP (Abcam ab1218)]. For puromycin treatment, cell lysates were treated with 25 µM puromycin 
for 15 min and cyclohexamide was omitted 169. 
 
Quantitative PCR  
 
QPCR analysis of RNA obtained from polysomes gradients was performed by collecting total and 
polysomal RNA and performing Trizol extraction as per manufactures protocol. RNAs were 
converted to cDNA using BioRad iScript cDNA synthesis kit and assessed by quantitative real-
time PCR using SensiFAST SYBR No-ROX Kit (Bioline) using the following settings: Hot start 
@ 95oC for 5 minutes; (denaturation for 5 sec @ 95oC, annealing/extension @ 60oC for 10 sec) x 
40 cycles. Relative translation efficiency was calculated by taking the ratio of polysomal RNA to 
total RNA and normalized using the ΔΔCt method. Primers used are listed in Supplementary 
Table 2. Values presented represent mean enrichments over a minimum of three biological 
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replicates.  
 
Co-Immunoprecipitation  
 
Crosslinking of RNA/protein complexes was performed as described by Niranjanakumari, S, 2002 
203. Briefly, one 15cm plate of HEK293T cells were stressed with 20uM clotrimazole for 0, 60, or 
120 mins. Cells were washed twice with 1X PBS and crosslinked with 1% formaldehyde for 10 
minutes at room temperature. The reaction was stopped with 0.25M glycine pH 7.0 for 5 minutes 
at room temperature. Cells were washed twice in 1X PBS followed by lysis in 1 mL RIPA buffer 
with DNase treatment (4U, 5 minutes at 37oC). Protein G beads were incubated with anti-La 
antibody or anti-GFP antibody for one hour at room temperature. Lysates were added to the beads 
and incubated for 2 hours at 4oC. Beads were washed twice with 500 uLs RIPA buffer (10 mM 
Tris-HCl pH8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM 
NaCl, 1 mM PMSF), three times with 500 uLs of PNK buffer (50 mM Tris-HCl pH 7.0, 5 mM 
EDTA, 10 mM DTT, 1% SDS), followed by reversal of crosslink by incubation at 70oC for 45 
minutes. RNA was Trizol extracted followed by isopropanol precipitation. Input and eluted RNAs 
were converted to cDNA using BioRad iScript cDNA synthesis kit and assessed by quantitative 
real-time PCR using SensiFAST SYBR No-ROX Kit (Bioline) using settings mentioned above.  
 
Individual-nucleotide resolution crosslinking and immunoprecipitation (iCLIP) 
 
iCLIP analysis was performed as described by Broughton et al. 2013 and Huppertz 2014 29,204. 
Briefly, HEK293 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). 
Cells were left untreated or treated with 20uM clotrimazole in serum free media for 1 hour, UV-
crosslinked (Stratalinker at 254 nm, 150 mJ/cm2), and lysed in RIPA buffer.  Lysates were then 
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treated with 10µl of 1:250 RNAse I (100U/µl AM2294 Invitrogen) and 2 µl DNase I (2U/µl 
AM2238 Ambion) at 37oC for 3 mins. RNA/La complexes were immunopurified with 10 µg anti-
SSB monoclonal antibody (abcam 75927) conjugated to 100 µl protein G Dynabeads (Invitrogen). 
RNAs bound by La were dephosphorylated at their 3′ end followed by on bead ligation of the DNA 
linker 5′-rAppAGATCGGAAGAGCGGTTCAG/ddC/-3′ (TriLink BioTechnologies). After 5′ end 
radiolabeling, crosslinked La-RNA complexes were size-separated by SDS-PAGE and transferred 
onto a nitrocellulose membrane. Regions corresponding to 40–70 kDa on the autoradiogram were 
extracted from the nitrocellulose membrane and RNAs were released from bound protein via 
proteinase K treatment. After reverse-transcription of the RNA, the cDNA was size-selected by 
running a 6% TBE-urea gel followed by gel extraction. Purified cDNAs were circularized using 
CircLigase (epicentre), linearized using BamH1 (NEB) restriction digestion, and PCR amplified 
using accuprime (Invitrogen) with P3Solexa /P5Solexa primers. (P5 Solexa: 5'-
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC
T -3'; P3 Solexa:  5'-CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGA 
ACCGCTCTTCCGATCT-3'. PCR amplified products were confirmed by running a 6% TBE and 
gel extracted. iCLIP cDNA libraries were submitted to The Centre for Applied Genomics at The 
Hospital of Sick Children for high-throughput sequencing on an Illumina GA-IIx (50 nt single end 
reads).  
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3.4 Results 
Mitochondrial stress induces subcellular relocalization of La/SSB  
Previous work on viral infection and cellular stress have suggested that hLa can be 
recruited to the cytoplasm under certain conditions 56,87,109,110. The first studies showing migration 
of La from the nucleus to cytoplasm were done in cells infected with poliovirus where it was shown 
that cytoplasmic translocation of La is mediated by the cleavage of the peptide bond between 
Gln358 and Gly359 by 3C62, a poliovirus-specific protease 89,173. In apoptotic cells, hLa is rapidly 
dephosphorylated by a PP2A-like phosphatase at S366, resulting in the cleavage of the nuclear 
localization signal (NLS) and subsequent redistribution of the protein from the nucleus to the 
cytoplasm 205,206. Both these examples illustrate that cytoplasmic distribution of hLa can occur via 
multiple mechanisms and may be context specific. To observe hLa relocalization in the presence 
of stress granules, we treated cells with clotrimazole, a well-characterized inducer of stress 
granules that inhibits mitochondrial function. Using immunofluorescence, we monitored the 
subcellular distribution of hLa in response to the formation of stress granules. Consistent with 
literature, we observed formation of stress granules by clotrimazole at a minimum concentration 
of 20uM for 30 mins (Supplementary Figure 4). Using this concentration, we performed a time 
course from 0-120 minutes in 30 minute intervals to observe changes in localization of hLa using 
HeLa cells. As expected, before induction of stress, La was observed to be predominately nuclear; 
however, 30 minutes post administration of the drug, we observed the formation of stress granules 
and a gradual shift of nuclear La into the cytoplasm (Figure 16). By 60 minutes post induction of 
stress, a greater percentage of La was seen dispersed in the cytoplasm. Approximately 200 cells 
from each time point were counted and characterized as being nuclear, cytoplasmic, or both. While 
we visualized migration of La from the nucleus to the cytoplasm, we did not see La co-localize 
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with stress granules along with our positive stress granule marker, eIF4G. To assess whether this 
phenomenon was cell type specific, we attempted this experiment in HEK293T cells and U2OS 
cells and observed similar migration patterns (Supplementary Figure 5). From these findings, we 
hypothesized that although La is not recruited into stress granules, the formation of stress granules 
may signal for La to shift to the cytoplasm to interact with cellular mRNAs that become up-
regulated during cellular stress. In agreement with our data, recent findings have shown that 
nuclear La migrates into the perinuclear space to engage the Nrf2 IRES in response to oxidative 
stress 109 and serum-starvation of cells results in cytoplasmic localization of La and increased La 
driven translation of the RRBP1 IRES 110.   
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Figure 16: Cellular stress induces cytoplasmic localization of La 
HeLa cells were treated with 20uM clotrimazole to induce stress granules. Cells at the 0 time point 
were mock treated with DMSO. A time course was performed from 0-120 minutes in 30 minute 
intervals to visualize the movement of La (red) into stress granules. EIF4G was used as a stress 
granule marker (green). Nuclei were visualized by DAPI (blue). Approximately 200 cells from 
each time point were counted and characterized as being nuclear, cytoplasmic, or both (n=3). 
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Cellular stress increases La’s association with polysomes  
During cellular stress, the majority of mRNA translation is suppressed and stress granules 
are formed as storage sites for non-stress related messages and stalled translation complexes. 
Although PABP is not required for the formation of stress granules, it is hypothesized that PABP 
is recruited to stabilize the stored mRNAs and aid in re-activation of global translation upon the 
disassociation of the stress granule 207. Given the previous association of La with coding RNAs to 
promote cap-independent translation and our recent finding of La directly binding to the poly (A) 
tail of mRNAs 208, we postulated that La may shuttle to the cytoplasm during cellular stress to 
assist in cap-independent translation of stress related mRNAs in a situation where PABP may have 
been recruited away from actively translating messages into the stress granules. We hypothesized 
that stress induced by clotrimazole would result in increased association of La with polysomes. 
HEK293T cells were treated with 20uM clotrimazole for 30 and 90 minutes, polysome 
fractionated, and individual fractions from the sucrose gradients were subject to immunoblotting 
analysis to localize La and PABP (Figure 17). Treatment of cells with clotrimazole resulted in an 
accumulation of the 80S subunit and the collapse of polysomes, as expected. Interestingly, despite 
the decrease in the presence polysomes in our stressed condition, we observed an increase in 
association of La with polysomal fractions confirming that La (and presumably cytoplasmic La) 
associates with the remaining actively translating polysomes. Additionally, we observed PABP in 
both monosome and polysome containing fractions in non-stressed control cells; however, a 
decrease of PABP in polysomal fractions was observed in stressed cells as has been previously 
demonstrated209. We confirmed these results in the context of a GFP-La transfected plasmid 
(Supplementary Figure 6). While we observed GFP-La to associate with polysomes 60 minutes 
post stress, we observed GFP empty vector to be present only in the first few fractions along with 
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free RNA.  To confirm that the sedimentation of our polysomes are dependent on active translation 
and the observed higher molecular weight complex is indeed caused by polysomes, we treated 
cells with puromycin, a destabilizer of polysomes that promotes premature termination. As 
expected, treatment of cells with puromycin resulted in disruption of polysomes and the absence 
of both La and Rpl9 in polysomal fractions.  
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Figure 17: Cellular stress increases La’s association with polysomes 
Top: Trace of ribosomes/polysomes fractionated from HEK293T cells untreated and stressed with 
20uM clotrimazole for 90 minutes. Bottom: Presence of proteins in each fraction was analyzed by 
western blotting using antibodies against La, PABP, and Rpl9. Presence of polysomes in higher 
weight fractions was confirmed by treating cells with puromycin. 
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La affects translational regulation in response to cellular stress 
 
The ability of cells to adapt and respond to cellular cues and stresses is vital for its survival. 
During cellular stress, a subset of messages (often encoding for proteins that are essential for that 
specific stress) are translationally upregulated. In an attempt to identify La dependent messages 
that are upregulated during clotrimazole induced cellular stress, we used polysome profiling as 
previously described coupled with qPCR. By measuring the percentage of a particular mRNA 
within polysomal fractions, we were able to assess its translational efficiency. We calculated 
relative translatability of mRNAs by normalizing abundance in polysomal fractions to abundance 
in total RNA (poly/total) under different cellular conditions. We first tested known mRNA targets 
of La including those that contain IRESs and uORFs (BiP, CCND1, LamininB1, and MDM2), 5' 
TOPs (RPL37 and eEF1b), and a non La related target (GAPDH). We first evaluated changes in 
translation efficiency of these genes in response to cellular stress (Figure 18b).  While we observed 
a general increase in translation of the BiP, Laminin B1, and MDM2 mRNAs, we saw decrease in 
overall translation of eEF1b and RPL37 as a result of cellular stress.  The observed decrease in 
translation of the two tested 5' TOP messages is likely reflective of its translational repression as 
has been observed in human cells previously 68. We also observed no overall change in translation 
of GAPDH in response to cellular stress as has been previously demonstrated210. In addition, 
although previous reports have identified La to promote translation from the IRES of the CCDN1 
mRNA during tumorigenesis in cervical cancer cells58, we did not observe any change in 
translation of this message and suspect this particular mRNA may not be actively translating in 
cells undergoing mitochondrial stress.    
To monitor the dependency of La on these messages to maintain active translation during 
cellular stress, we performed knockdown of La using a previously validated siRNA58. As complete 
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La knockout is lethal to eukaryotic cells resulting in apoptosis and cell death, we used samples 
where we achieved ~50% knockdown of La. Experimental trials showing desired levels of La 
knockdown were used for polysome fractionation and subsequent qPCR (Figure 18a). As 
expected, knockdown of La resulted in a decrease in translation of BiP and Laminin B1. However, 
no significant change in translational efficiency was observed for MDM2 and eEF1b. Knockdown 
of La resulted in an increase in translatability of RPL37, further validating the proposed function 
of La in inhibiting translation of 5' TOPs 68.  
To confirm if the observed changes in translation of our tested messages are a result of 
direct association with La, we performed a time course and immunoprecipitated hLa in untreated 
and clotrimazole treated cells along with its associated transcripts in the context of a reversible 
formaldehyde crosslink and determined relative abundance using qPCR (Figure 18c).  As a 
negative control, we immunoprecipitated using an anti-GFP antibody. With the exception of 
GAPDH, we observed a general overall increase in association of La with our tested substrates in 
clotrimazole treated cells, albeit to varying extents. Maximum immunoprecipitation of our 
substrates was observed after 120 mins of drug exposure. Thus, our immunoprecipitation data 
suggest that the observed translational changes we see in our polysome analysis are a direct result 
of La’s association with these particular messages.  
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Figure legend on next page. 
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Figure 18: La binds mRNAs to regulate cap-independent translation 
(A) HEK293T cells were transfected with a control siRNA or a siRNA targeting La. 24 hours post 
transfection, cells were treated with 20uM clotrimazole for 60 minutes to induce mitochondrial stress. 
Cells were then harvested and subject to western blot analysis before preparation for polysome analysis 
(left panel). Western blots were imaged using the MicroChemi Bioimaging System and quantified 
using ImageJ. Three biological replicates were performed and the relative knockdown was calculated 
(right panel). Error bars indicate standard deviation. (B) HEK293T cells from (A) were subject to 
polysome fractionation and subsequent qPCR analysis. Translational efficiency of known La 
mRNA targets that contain IRESs, uORFs, and 5' TOPs were tested along with a non La related 
target (GAPDH) by calculating ratio of poly/total RNA. Unstressed cells were set to “1”. Error 
bars indicate standard deviation of three biological replicates and asterisks highlight statistically 
significant changes (*= P<0.05, **=P<0.01 two-tailed student t-test). (C) Time course of La co-
immunoprecipitated with its associated transcripts during cellular stress measured by qPCR. 
Efficiency of pulldown is measured relative to co-immunoprecipitation with an anti-GFP antibody. 
Error bars correspond to standard deviation of a minimum of three biological replicates, asterisks 
highlight statistically significant changes (**=P<0.01, *** P<.001 two-tailed student t-test). 
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Identification of new La associated stress targets 
To date, IRES containing messages upregulated during cellular stress and interact with La 
include Laminin B1, XIAP, BiP, CCND1 and Nrf2, and RRBP1 56,58,108–110,115. In an attempt to 
identify novel messages that associate with La during compromised cellular conditions, we 
performed individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP). 
Stressed and unstressed HEK293T cells were UV cross linked to covalently bind protein-RNA 
molecules and immunoprecipitated using an anti-La antibody. Protein-RNA complexes were 
subject to partial RNAse I digestion. RNA bound by La was isolated using an anti-La antibody, 
reverse transcribed, and PCR amplified for next generation sequencing.  
Using iCLIP, we not only identified messages bound by La, but we also identified 
approximate site(s) of the interaction. Interestingly, several newly identified substrates were 
mRNAs that have previously been demonstrated to contain cellular IRESs such as Bag1, HIF-1 
alpha, and TP53 211–213. Messages containing previously identified IRES elements, along with 
messages upregulated in our stress induced condition (particularly those that showed an interaction 
occuring near the 5' UTR where a potential IRES would be located) were selected for further 
examination. Presented in Table 3 is a list of selected genes, along with gene ID and gene 
description. While IRES elements have been identified within the mRNAs of BAG1, HIF1-alpha, 
TP53, Apaf1, and RBM3 in human cells, the YAP1 IRES has only been identified in 
Saccharomyces cerevisiae to date 211–217. To assess the ability of these messages to translate during 
cellular stress and to measure the dependency of La for efficient translation, we repeated the 
polysome/qPCR experiment as previously mentioned. As expected, several of our tested IRES 
containing messages showed increased translation efficiency upon cellular stress (Figure 19a). 
Although the HSPA1A and BCL2L2 mRNAs do not contain a known IRES, these particular 
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mRNAs displayed a similar trend to the other tested IRESs.  Unlike typical 5' TOPs, which begin 
with a cytidine followed by a stretch of up to 15 pyrimidine residues, the HSP90AB1 gene, 
encoding for a member the heat shock protein family, contains a “TOP-like” motif consisting of a 
shorter stretch of pyrimidine residues 214.  We show that unlike our previously tested 5' TOPs 
(eEF1b and RPL37), HSP90AB1 is upregulated by cellular stress, but its ability to effectively 
translate is not deterred by knockdown of La. Lastly, we tested a long non-protein coding RNA, 
XIST, and measured the effects of cellular stress on the translation of this message. The XIST 
RNA functions to silence one of the pair of X chromosomes in females in order to provide equal 
expression of genes between males and females 218. We show that the translation efficiency of this 
specific RNA is not affected by the induction of cellular stress nor by the silencing of La. 
Immunoprecipitation of La with its associated messages once again revealed that the observed 
translational changes we see in our polysome analysis are a direct result of La’s association with 
these particular messages with more association occurring at either 60 or 120 mins post 
administration of stress (Figure 19b). Taken together, our data reveal that La associates with 
several previously unidentified IRES containing messages and that this interaction occurs as a 
response to cellular stress. 
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Table 3: Selected target genes from iCLIP  
 
GENE 
NAME 
ENSEMBL  
GENE ID 
GENE TYPE TRANSLATIONAL 
ELEMENT 
GENE DESCRIPTION 
BAG1 ENSG00000107262 Coding RNA IRES211 BCL2 associated athanogene 1 
HIF1A ENSG00000100644 Coding RNA IRES212 hypoxia inducible factor 1 alpha subunit 
TP53 ENSG00000141510 Coding RNA IRES213 tumor protein p53 
APAF1 ENSG00000120868 Coding RNA IRES217 apoptotic peptidase activating factor 1 
YAP1 ENSG00000137693 Coding RNA IRES216 Yes associated protein 1 
HSPA8 ENSG00000109971 Coding RNA IRES219 Heat shock protein 70 alpha family member 8 
HSP90AB1 ENSG00000096384 Coding RNA 5' TOP-like 214 Heat shock protein 90 alpha family class B member 1 
BCL2L2 ENSG00000129473 Coding RNA - BCL2 like 2 
HSPA1A ENSG00000204389 Coding RNA - Heat shock protein 70 alpha family member 1A 
XIST ENSG00000229807 Long non coding RNA - X inactive specific transcript 
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Figure legend on next page. 
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Figure 19: La’s association with mRNAs during cellular stress 
(A) HEK293T cells were subject to polysome fractionation and subsequent qPCR analysis as 
previously described. Translational efficiency of mRNA targets identified from iCLIP analysis 
was measured by calculating ratio of poly/total RNA. Unstressed cells were set to “1”. Error bars 
indicate standard deviation of three biological replicates and asterisks highlight statistically 
significant changes (*= P<.005, **=P<.01 two-tailed student t-test). (B) Time course of La co-
immunoprecipitated with associated transcripts during cellular stress measured by qPCR. Error 
bars correspond to standard deviation of a minimum of three biological replicates, asterisks 
highlight statistically significant changes (*= P<0.05, **=P<0.01, *** P<.001 two-tailed student 
t-test). 
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3.5 Discussion 
Cytoplasmic redistribution of La during cellular stress occurs to promote translation of 
stress associated messages 
 
Several IRES trans-acting factors are upregulated during suboptimal cellular conditions 
such as viral infection, cellular stress, and tumor progression. These proteins often undergo various 
modifications to engage their RNA target including phosphorylation, increased protein expression, 
and nuclear-cytoplasmic shuttling 200,201. In this study, we aim to decipher the role of hLa during 
cellular stress, specifically to further understand the conditions during which this protein is 
exported to the cytoplasm, the mechanism by which this occurs, and novel RNA substrates bound 
by La. We report here that the La protein undergoes subcellular relocalization upon exposure to 
clotrimazole, an inducer of mitochondrial stress and stress granules. Previous reports have shown 
similar shuttling of nucleoplasmic La to the cytoplasm under conditions of oxidative stress, serum 
starvation, tumor progression, and viral infection suggesting that this redistribution of La is not 
specific to mitochondrial stress or to the formation of stress granules 56,58,108–110,115. Using a 
combination of polysome analysis and qPCR we show increased association of La with stress 
associated messages in response to cellular stress, specifically those that contain IRESs and 
uORFs. Using iCLIP, we then identify several new La associated messages and demonstrate a La 
dependency for these messages to effectively translate during cellular stress. 
 
Human La function in cap-independent translation 
The human La protein is most associated with the processing of nascent RNA polymerase 
III transcripts, but also plays a role in promoting cap-independent translation for several cellular 
and viral coding RNAs. In the nucleus, La is recruited to nascent RNA polymerase III transcripts, 
 111 
such as pre-tRNAs, via sequence specific recognition of UUU-3'OH 54,149. Although the 
mechanism by which La interacts with its nuclear substrates is well established, the mechanism by 
which La interacts with its cytoplasmic substrates appears to be more complex and context 
specific. Cytoplasmic La is often associated with messages that contain atypical translation 
initiation contexts such as 5' TOPs and IRESs 68. Given that a significant 20% of mRNAs in cells 
contain 5' TOPs and that these mRNAs often encode ribosomal proteins and other components of 
translational machinery, it can be postulated that hLa’s interaction with these messages serves to 
either directly or indirectly regulate the translation of essential proteins 220. The role of La in the 
translation of 5' TOPs has been controversial with some studies suggesting that La enhances 
translation in Xenopus oocytes177,221, while others suggest that La represses 5' TOP translation in 
human cells68,222. Our data presented in figure 18b, are consistent in showing that La displays an 
inhibitory effect on 5' TOP translation during cellular stress for some messages. La was the first 
ITAF discovered bound to poliovirus and since then identified as a key factor for the enhancement 
of IRES dependent translation by functioning as an RNA chaperone 99,158. Human La can induce 
translation of IRES containing viral mRNAs including Hepatitis B Virus 156, Hepatitis C Virus 176, 
Coxsackievirus B3 223, and encephalomyocarditis 57, along with cellular mRNAs including BiP 56, 
XIAP 198, Laminin B1 115, CCND1 58, Nrf2 109, RRBP1110, and the upstream open reading frame 
containing mRNA for the oncogene MDM2 116.  
 
Mechanism of La export to the cytoplasm 
One aspect of La shutting yet to be identified is an explicit signal or cue which causes La 
to undergo subcellular redistribution. In our experiments, we specifically used clotrimazole to 
induce stress granule forming stress and monitored the migration of La in the presence of stress 
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granules. While we observed La migrate into the cytoplasm, we did not visualize La to co-localize 
with the granules. Cytoplasmic redistribution of La has also been reported during glucose 
starvation, a stress granule forming stress, and oxidative stress caused by hydrogen peroxide, a 
non-stress granule forming stress 109,110. Monitoring the migration of La in response to a variety 
stresses that cause granule formation and those that do not, would help determine whether the 
cytoplasmic distribution is specific to certain types of stress or if it occurs as a general response to 
global homeostatic disruption. One question not addressed in this study is the possibility of La 
returning to its nuclear state once cells return to homeostasis. Cell fractionation of La performed 
in various studies indicate that protein expression levels remain the same during cellular stress and 
normal conditions and it is only the nuclear-cytoplasmic distribution that is altered, suggesting the 
possibility of La returning to the nucleus when homeostasis has been attained 109,115. 
Also yet to be identified is a common mechanism for La’s recruitment into the cytoplasm. 
Cytoplasmic translocation of hLa in apoptotic cells occurs through dephosphorylation at S366 
resulting in the cleavage of the nuclear localization signal 205,206. By contrast, murine La 
phosphorylated at Thr301 by AKT, shuttles to the cytoplasm and regulates mRNA translation in 
mouse glial progenitors 224. In human cells undergoing epithelial-mesenchymal transition, it is 
hypothesized that AKT induced cytoplasmic shuttling of La promotes La binding to the Laminin 
B1 IRES, but the exact mechanism is unknown 115. Surprisingly, in HeLa cells and rat 
cardiomyocytes, oxidative stress induced by H2O2 results in no apparent modifications of La 
suggesting the possibility of a carrier protein being involved in mediating export during this 
specific scenario 109. Taken together, these data suggest that nuclear-cytoplasmic redistribution of 
La can occur via different mechanisms and appear to be context specific. Performing co-
immunoprecipitation of La in the presence and absence of cellular stress coupled with mass 
 113 
spectrometry will allow for the detection of modifications made to hLa and identify possible carrier 
proteins that mediate nuclear export. There also exists the possibility of La being co-exported with 
newly synthesized RNA transcripts to the cytoplasm. Inhibiting transcription using actinomycin D 
and/or alpha-amanitin and monitoring the localization of La using immunofluorescence will allow 
to assess if La export is mediated by the ability of the protein to bind nascent transcribed RNAs 
that are destined for the cytoplasm. 
While our data do not provide a complete mechanism by which hLa translocates to the 
cytoplasm, our data are consistent with La being exported into the cytoplasm during cellular stress 
to assist in translation of upregulated messages. We have demonstrated using iCLIP and qPCR 
that our tested IRES containing messages are upregulated during cellular stress and display La 
dependency for translation during suboptimal cellular conditions. What remains to be tested is the 
specific nature by which La interacts with these messages. Previous research has indicated that the 
La motif, along with the C-terminal and N-terminal RNA recognition motifs are responsible for 
IRES dependent translation of the HCV IRES41.  Hence, it can be speculated that La may promote 
cellular mRNA translation through the same binding modes. Through the use of bicistronic 
reporter constructs and hLa-GFP mutants, it will be possible to determine the specific domains of 
the protein that are involved in binding to IRES elements.  
Cellular stress, specifically oxidative stress and mitochondrial stress haven been associated 
in the pathogenesis of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and 
amyotrophic lateral sclerosis (ALS)225. In addition, oxidative stress has been implicated in viral 
replication, and tumor progression. The ability of certain messages to adapt and overcome cellular 
stress while others remain translationally repressed can have dramatic implications on gene 
expression. Therefore, understanding the molecular mechanisms by which cells adapt to cellular 
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stress and promote translation during compromised conditions is imperative for the discovery of 
novel therapeutic targets for neurodegenerative diseases, viruses, and cancer. 
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3.7 Supplementary Figures 
 
 
 
 
 
 
Supplementary Figure 4: Stress granules induced using clotrimazole 
Stress granules were induced at a minimum concentration of 20uM clotrimazole in HeLa cells for 
30 minutes.  
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Figure legend on next page. 
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Supplementary Figure 5: Mitochondrial stress induces cytoplasmic relocalization of La  
(A) HeLa cells were treated with 20uM clotrimazole to induce stress granules. A time course was 
performed from 0-120 minutes in 30 minute intervals to visualize localization of La (red). EIF4G 
was used as a stress granule marker (green). Nuclei were visualized by DAPI (blue). (B) Time 
course of 0-90 mins performed on HEK293T cells and (C) U2OS cells. 
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Supplementary Figure 6: Polysome Analysis of GFP-La   
Trace of ribosomes/polysomes fractionated from HEK293T cells untreated and treated with 20uM 
clotrimazole for 60 minutes. Presence of transfected GFP-La in each fraction was analyzed by 
western blotting using GFP and Rpl9.  
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Supplementary Table 2: List of Primers 
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Chapter 4: 
 
Summary and Future Directions 
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4.1 General Summary 
The La protein, also referred to as Sjogren’s Syndrome antigen B (SSB), is an RNA-
binding phosphoprotein that shuttles between the nucleus and cytoplasm, interacting with RNA 
substrates transcribed by both RNA Pol III and Pol II. While hLa’s interaction with its nuclear 
substrates have been well characterized, La’s interaction with its cytoplasmic substrates is still 
under investigation. The objective of this study was to characterize the mechanism by which La 
recognizes its cytoplasmic targets, and to understand the context and mechanism by which La 
affects cap independent translation. In this work, we show 1) hLa binds to poly(A) sequences in 
vitro, 2) La binds to the poly(A) tail of mRNA to regulate translation, and 3) La is translocated 
from the nucleus to the cytoplasm in response to cellular stress in order to mediate cap independent 
translation during cellular stress.   
4.1.1 hLa binds mRNAs through contacts made to the poly(A) tail 
In the data presented in Chapter 2, we show that in addition to a sequence specific UUU-
3'OH binding mode, hLa exhibits a sequence specific and length dependent poly(A) binding mode 
and that La may regulate IRES mediated translation via contacts made to the poly(A) tail. La 
proteins have been linked extensively with the translation of mRNAs with atypical translation 
initiation contexts; however, it was previously hypothesized that La binds coding transcripts via 
non-specific recognition of structured RNA elements41. Using electromobility shift assays, we 
demonstrate that hLa has greater affinity for adenylate containing sequences compared to poly(C) 
or single stranded poly(G), and this occurs in a length dependent manner. Using both hLa point 
and deletion mutants, we further mapped this poly(A) binding mode to specific amino acids in the 
winged helix face of the LAM, previously shown to be vacant during uridylate binding, along with 
the two RRMs.  
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Given the previous association of La with the translation of coding transcripts and our in 
vitro results suggesting that La displays affinity for poly(A) sequences providing the sequence is 
extended, we hypothesized that La may function in mRNA translation via contacts made to the 
poly(A) tail. Using a cross-linking immunoprecipitation assay, we show that while wildtype hLa 
directly engages and immunoprecipitates poly(A) RNA in human cells, hLa constructs with 
mutations in the winged helix fold display impaired binding to poly(A) and fail to 
immunoprecipitate poly(A) RNA, but still immunoprecipitates pre-tRNA Met-e. To assess if the 
poly(A) binding mode could play an important role in La’s capability to enter polysomes and 
associate with actively translating messages, we performed polysome fractionation. Unlike 
wildtype hLa, which was found in polysomal fractions, our hLa mutant was found exclusively at 
the top of the polysome gradient, suggesting a decrease in its ability to enter polysomes.  
We then tested the importance of the poly(A) dependent binding mode on La’s capacity to 
promote both cap- dependent and independent translation using a well characterized substrate of 
La, the IRES of the cyclin D1 mRNA. We observed that overexpression of La resulted in an 
increase of both cap- dependent and independent translation, and that La mutants displayed 
diminished ability to drive translation.  To further understand if the interaction of La with the 
poly(A) tail occurs in competition with the cytoplasmic poly(A) binding protein, we overexpressed 
both PABP and La. Overexpression of PABP resulted in a decrease in La driven cap independent 
translation, indicating possible competition between La and PABP for the poly(A) tail. The data 
presented in Chapter 2 provides us with a possible mechanism through which La may interact with 
its cytoplasmic substrates, functioning to drive cap independent translation via contacts made with 
the poly (A) tail. 
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4.1.2 Cellular stress induces the cytoplasmic localization of La and increased 
association with stress associated mRNAs 
In Chapter 3, we report that the hLa protein undergoes subcellular re-localization upon 
exposure to clotrimazole, an inducer of mitochondrial stress, and displays increased association 
with messages that are upregulated during stress. Using immunofluorescence to monitor the 
movement of La upon stress induction using clotrimazole, we show the gradual migration of La 
from the nucleus to the cytoplasm. While La is observed to be diffuse in the cytoplasm, it does not 
co-localize with stress granules. Previous reports have shown similar shuttling of nucleoplasmic 
La to the cytoplasm under conditions of oxidative stress, serum starvation, tumour progression, 
and viral infection suggesting that this translocation is not specific to mitochondrial stress 56,58,108–
110,115. 	
Given the previous association of La with the translation of coding RNAs that contain 
atypical translation initiation contexts, which also happen to be upregulated during cellular stress, 
we postulated that La may shuttle to the cytoplasm during cellular stress to assist in cap-
independent translation of stress related mRNAs. HEK293T cells treated with clotrimazole were 
subject to polysome fractionation and immunoblotting was performed to identify the localization 
of La and PABP. Our polysome analysis data showed that despite the decrease in the presence of 
polysomes in stressed cells, an increased association of La with polysomal fractions. Given that 
cellular stress results in a general decrease of cap dependent translation and an increase in IRES 
dependent translation, it is probable that La is associating with these upregulated IRES containing 
messages. Interestingly, we also observed a decrease in the association of PABP with polysomal 
fractions of stressed cells compared to non-stressed cells. Since PABP is recruited to stress 
granules during stress to stabilize stored mRNAs and aid in the re-activation of global translation 
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upon stress granule disassociation, it is plausible that La is recruited to the cytoplasm to assume 
some roles of PABP. Using iCLIP, we have identified novel substrates of La and mRNAs that are 
upregulated during clotrimazole induced cellular stress. Interestingly, some of the identified La 
substrates contain previously established IRES elements in their 5' UTR. Using qPCR analysis, we 
demonstrated that these messages are not only upregulated during cellular stress, but are also 
dependent on La for optimal translation during suboptimal cellular conditions. In summary, our 
data show that hLa is trafficked into the cytoplasm in response to clotrimazole induced cellular 
stress to associate with messages that rely on alternate mechanisms to promote translation during 
compromised cellular conditions.  
4.2 Future Directions  
4.2.1 Mechanistic interplay of La and PABP at the poly(A) tail 
Although we provide a potential novel mechanism through which La interacts with its 
cytoplasmic substrates to regulate translation, at the same time, several questions have emerged 
from this study that have yet to be answered. We propose that La functions in translation via 
contacts made directly with the poly (A) tail. For mRNAs where the poly(A) tail is present, our 
results demonstrate that La may interact with these messages in a manner analogous to which it 
interacts with its UUU-3'OH RNA Pol III substrates. However, whether La binds the poly(A) tail, 
remains bound while looping around the RNA to gain access to the 5' UTR and the IRES, or if La 
is recruited to the poly(A) tail and then translocates to these sites is still unclear. Although previous 
work has hypothesized the possibility of La simultaneously binding to both the poly(A) tail as well 
as other regions of mRNA, it has not been experimentally proven 40,41,180.  Similarly, the precise 
nature by which PABP and La interact at the poly(A) tail is also unknown. In addition, it is still 
not known if La and PABP always compete for poly (A) tail binding or if certain cellular conditions 
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cause La to assume the role of PABP. This could occur when PABP has been recruited to stress 
granules to help stabilize stalled translating messages that occurs with exposure to exogenous 
stress or viral infection.   
Interestingly, several La associated plus-strand viral mRNAs containing IRESs including 
poliovirus, encephalomyocarditis virus (EMCV) and coxsackievirus B3 (CBV3), have all been 
identified to harbour a poly(A) tail where its presence has been shown to enhance the translation 
of viral mRNA 226,227. In addition, although the Hepatitis C virus does not naturally contain a 
poly(A) tail, increased IRES driven translation has been observed when a poly(A) tail was 
artificially engineered to the 3'OH end 226,228. It has also been proposed that viral IRESs promote 
translation via different mechanisms and that PABP may not be the only RBP that binds the 
poly(A) tail of these viral messages. For certain picornaviruses such as EMCV and polio, it has 
been shown that viral replication and IRES mediated translation occur in cell-free extracts that 
have been depleted of PABP 227. Thus, it would be fascinating to test whether La enhances the 
translation of these viral messages through contacts made with the poly(A) tail.  
4.2.2 La-motif mediated poly(A) binding in the LARP families 
 While genuine La proteins facilitate the processing of both RNA Pol II and RNA Pol III 
transcripts, the LARP families have evolved to only target one of these classes. Although the LAM 
remains highly conserved amongst all the LARP families, differences appear in the adjacent linker 
bridging the LAM and the N-terminal RRM. While this linker in La is long and flexible in its 
RNA-free form, the corresponding linker in LARP families 4 and 6 (LARP4 and LARP6) appears 
to be shorter and rigid 42. It is plausible that the difference in the flexibility and the length of the 
linker may be the distinguishing factor that allows the La protein to function in the binding of both 
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the poly(A) and poly (U) transcripts, while the LARP families are restricted to targeting only one 
of these classes,	although this has yet to be tested. Another question that needs to be answered is 
whether the LARP families also use the highly conserved LAM to regulate translation. Members 
of the LARP1, LARP4, and LARP6 families are associated with mRNA translation via the direct 
interaction with PABP. Additionally, human LARP1 and LARP4 have been shown to directly bind 
poly(A) in a manner parallel to La. It will be vital to perform structural analyses to determine if 
these LARP families use the same residues in the winged helix fold of the LAM to bind to poly(A). 
4.2.3 Alternate cellular cues that induce cytoplasmic localization of La 
We show that under certain conditions, La is recruited to the cytoplasm to assist in the 
translation of stress associated messages; however, several questions emerging from this work are 
yet to be resolved. While the cytoplasmic redistribution of La has been reported during glucose 
starvation and oxidative stress (hydrogen peroxide), there are several other forms of stress with the 
potential to elicit similar responses that have not been tested. Cell exposure to osmotic shock and 
oxidative stress (e.g., arsenite), as well as non-chemically induced stresses such as hypoxia, heat 
shock, and UV radiation, would allow us to determine whether the migration of La to the cytoplasm 
is specific to certain types of stress or if this migration occurs as a general response to global 
homeostatic disruption.   
Unlike stress induced by hydrogen peroxide, oxidative stress that is induced by arsenite 
results in the formation of stress granules. Consequently, although both these stressors induce the 
production of reactive oxygen species, key translational machinery is recruited to stress granules 
with arsenite exposure, but is not with hydrogen peroxide. Therefore, it would be interesting to 
monitor and compare the similarities and differences of the function of La in the presence of each 
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of these stressors. It would also be important to detect the movement of La once cells have adapted 
to or overcome cellular stress and are undergoing recovery. In distinct studies, cell fractionation 
indicate that La protein expression levels remain the same during both stress and normal 
conditions, and only the nuclear-cytoplasmic distribution of La is changed 109,115. Although it still 
must be tested and proven, this suggests that La may have the potential to return to the nucleus 
when the cell returns to homeostasis. 
4.2.4 Mechanism of La shuttling between nucleus and cytoplasm 
An interesting area to explore is the function of La in viruses that stimulate cellular stress, 
since several La associated viral messages promote translation by inducing stress to recruit cellular 
machinery. hLa was identified as the first IRES ITAF due to its ability to enhance translation of 
polioviral RNA158. Interestingly, poliovirus can also induce the formation of stress granules in 
cells 229. The cytoplasmic distribution of La infected cells is shown to be mediated by cleavage of 
the peptide bond Gln358 and Gly359, by “3C62” a poliovirus-specific protease 89,173. Additionally, 
the well-characterized La associated virus, Hepatitis C, has been shown to induce oxidative stress 
in infected cells and induce stress granules 111,230. Although the mechanism has not yet been 
identified, increased cytoplasmic distribution of La has been observed within infected cells, along 
with the increased association of La with the HCV IRES 111. Further studies examining the 
interaction of La with other picornaviral and HCV-like IRESs under oxidative stress may reveal 
more information about the mechanism through which La is recruited to the cytoplasm to promote 
IRES dependent translation and viral replication.		
A common mechanism for La recruitment to the cytoplasm is yet to be identified. In 
apoptotic cells, hLa is dephosphorylated and the nuclear localization signal is cleaved causing the 
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cytoplasmic distribution of La 205,206. By contrast, murine La phosphorylated by AKT results in 
cytoplasmic translocation 224. Surprisingly, oxidative stress induced by hydrogen peroxide results 
in no apparent hLa modifications, suggesting that a carrier protein may be involved in mediating 
nuclear export 109. This suggests that the nuclear-cytoplasmic redistribution of La appears to be 
context-specific and can occur through distinct mechanisms. Performing co-immunoprecipitation 
of La during cellular stress coupled with mass spectrometry will allow us to detect modifications 
made to hLa and identify possible carrier proteins that mediate nuclear export. One site of interest, 
located within the NLS of hLa (T389), is known to be phosphorylated by AKT 69.  There also 
exists the possibility of dysfunction of nuclear import of La during cellular stress resulting in 
increased accumulation of the protein in the cytoplasm. Additionally, the question of whether La 
can be co-exported with newly synthesized RNA transcripts to the cytoplasm has yet to be 
addressed. This can be tested by inhibiting transcription using actinomycin D and/or alpha-
amanitin and monitoring the localization of La using immunofluorescence. By inhibiting 
transcription and examining the localization of La during cellular stress, we will be able to assess 
if La export is mediated by the ability of La to bind nascent transcribed RNAs, destined for the 
cytoplasm.  
4.3 Conclusion  
In this dissertation, we have attempted to further characterize the mechanisms through 
which hLa recognizes and interacts with its cytoplasmic targets to regulate translation. Our results 
demonstrate that in addition to a sequence specific UUU-3'OH binding mode, hLa exhibits a 
sequence specific and length dependent poly(A) binding mode, mapped to the canonical winged 
helix face of the eponymous LAM.  Additionally, we have shown that cytoplasmic La engages 
poly(A) RNA in human cells and that La promotion of translation from the cyclin D1 IRES occurs 
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in competition with cytoplasmic PABP. In an effort to understand the cellular conditions during 
which La interacts with its cytoplasmic substrates we show that stress induced by clotrimazole 
causes the translocation of La from the nucleus to the cytoplasm and that this translocation is 
concurrent with the increased association of La with actively translating messages. Using iCLIP, 
we identify novel mRNAs that are La dependent for translation during cellular stress. Taken 
together, this data suggests that hLa is trafficked into the cytoplasm in response to cellular stress 
in order to associate with IRES containing messages, and this interaction may occur through 
contacts made with the poly (A) tail.   
Gene regulation is a fundamental process responsible for the development and survival of 
an organism. The ability of certain messages to adapt and overcome cellular stress while others 
remain translationally repressed can have dramatic implications on gene expression. As the ability 
of cells to maintain active translation in response to cellular stress is vital for its survival, cells 
have evolved and adopted various mechanisms to adapt and overcome cellular stress. Cellular 
stress has been associated with the pathogenesis of neurodegenerative diseases, viral replication, 
and tumor progression. Therefore, understanding the molecular mechanisms by which cells adapt 
to cellular stress and promote translation using atypical translation initiation contexts during 
compromised conditions can lead to the discovery of novel therapeutic targets for 
neurodegenerative diseases, viruses, and cancer. 
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Appendix 
Selected Materials and Methods 
Maintaining Cell Culture 
HEK293T, HeLa, and U2OS cells were obtained from ATCC and cultured in DMEM media with 
serum. Cells were regularly passaged and maintained for 30-40 passages and then discarded. 
 
Reagents 
DMEM   GIBCO 11965-092 
PBS     MultiCell 311-010-C1 
Fetal Bovine Serum   Sigma F1051 
Pencillin   ThermoScientific 15140122 
Trypsin   Hyclone SV30031.01 
DMSO    BioShop DMS555.500 
 
Cell Passaging 
1) Aspirate media. 
2) Rinse cells with 5-10mLs of 1x PBS. 
3) Add 1mL of Trypsin and incubate at 37oC for 2 mins. 
4) Inactivate trypsin by adding 9mLs of DMEM. 
5) Pipette cells several times to avoid cell clumping. 
6) Add 1mL of cells to 9mL of DMEM media containing 10% FBS and 2% antibiotics. 
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DNA/RNA Transfection 
DNA was prepped using Qiagen Plasmid Midi Prep Kit. Transfections were performed either 
with PolyJet or Lipofectamine 2000. PolyJet was used for DNA transfections. Lipofectamine 
was used for RNA or DNA/RNA co-transfections. Transfections were scaled up or scaled down 
according to manufacture’s protocol. 
 
Reagents 
Plasmid Midi Prep Kit  Qiagen 12143  
PolyJet    SignaGen SL100688 
Lipofectamine    Invitrogen 11668-019 
OPTIMEM    GIBCO 31985-070 
DMEM    GIBCO 11965-092 
 
PolyJet transfection 
1) Plate cells in plates 18-24hrs pre transfection to a confluency of 70-80% in media with 10% 
FBS excluding antibiotics. 
2) 1 hour prior to transfection, change media for cells.  
3) Dilute DNA in serum-free DMEM media and dilute PolyJet in serum-free DMEM media in 
separate tubes. 
4) Immediately add diluted PolyJet to the diluted DNA, pipette up and down to mix DNA with 
PolyJet and incubate at room temperature for 10-15 mins. 
5) Add PolyJet/DNA mixture to cells in a drop wise manner. Incubate at 37oC. 
6) Change media 6-8 hrs after transfection. 
 
 
Lipofectamine transfection 
1) Plate cells in plates 18-24hrs pre transfection to a confluency of 70-80% in media with 10% 
FBS excluding antibiotics. 
2) 1 hour prior to transfection, change media for cells.  
3) Dilute DNA and/or RNA in Opti-MEM® I and dilute Lipofectamine in Opti-MEM® I in 
separate tubes. 
4) Add diluted DNA to the diluted lipofectamine, pipette to mix DNA/RNA with Lipofectamine 
and incubate at room temperature for 15-20 mins. 
5) Add Lipofectamine/DNA mixture to cells in a drop wise manner. Incubate at 37oC. 
6) Change media 6-8 hrs after transfection. 
 
*For knockdown of La, use 100nM of siRNA. Maximum knockdown is seen 48 hours post 
transfection 
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In vitro RNA Transcription 
 
Reagents 
OneStep RT-PCR Kit      Qiagen 210210 
mMESSAGE mMACHINE® SP6 Transcription Kit Ambion 1340 
 
1) Extract RNA from HeLa cells using Trizol as per manufacturer’s protocol.  
2) Obtain HeLa poly(A) derived cDNA using the OneStep RT-PCR Kit. 0.5ug of RNA was 
used as template as per manufactures protocol. 
3) Clone IRES into the SalI-BamHI site of the pDL-N dual luciferase construct using restriction 
enzymes. 
4) Use construct as a template for a PCR reaction using primers to add an SP6 promoter 
upstream of the renilla 5' UTR and a 20A sequence, 40A sequence or a histone mRNA 
SLBP-binding stem loop after the firefly 3' UTR.  
5) Run agarose gel to confirm PCR product. 
6) Use 1ug DNA template to transcribe RNA using mMESSAGE mMACHINE® SP6 
Transcription Kit. 
7) Run reaction overnight at 37oC. 
8) Run 1ul transcribed product on agarose gel to confirm transcription reaction. 
9) Precipitate RNA using lithium chloride as per manufacture’s protocol. 
10) Quantify RNA using nanodrop. 
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Luciferase Assay 
 
Reagents  
Dual-Luciferase Reporter Assay System   Promega E1910 
White 96-Well Immuno Plates    ThermoScientific 14-245-196Q 
 
1) Wash adherent cells with 1X PBS. 
2) Add 20uls of lysis buffer/well (supplied by Promega) in 96 well plate. Dilute lysis buffer 1:5 
in ddH20 and supplement with 1% Protease Inhibitor Cocktail and 1% PMSF. 
3) Harvest cells. Collect 15uls and place in an opaque white 96 well plate (Costar) 
4) Keep lysate on ice until read using Synergy H4 
5) Record numbers for Firefly (Dispenser 1) and Renilla (Dispenser 2) 
 
Synergy H4 Procedure Details:   
 
Dispense: 45 µL, Dispenser 1, Rate 250 µL/sec, Tip prime, 10 µL   
Read Luminescence Endpoint    
 Integration Time: 0:01.00 (MM:SS.ss)   
 Filter Set 1   
 Emission: Hole   
 Optics: Top,  Gain: AutoScale   
 Read Speed: Normal,  Delay: 100 msec     
Dispense: 45 µL, Dispenser 2, Rate 225 µL/sec, Tip prime, 10 µL   
Read Luminescence Endpoint    
 Integration Time: 0:01.00 (MM:SS.ss)   
 Filter Set 1   
 Emission: Hole   
 Optics: Top,  Gain: AutoScale   
 Read Speed: Normal,  Delay: 100 msec 
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Cross-linking and Immunoprecipitation (CLIP) 
Procedure adapted from Abcam 
 
Reagents 
Protein G Beads   Thermo Scientific 10003D 
Protease Inhibitor Cocktail  Thermo Scientific 78425 
RNAse Inhibitor   Ambion AM2696 
Sodium Deoxycholate   Sigma-Aldrich D6750 
TurboDNAse    Ambion 1340 
RNAse I    Ambion AM2295 
Proteinase K    Thermo Scientific 100005393 
Decade Markers    Ambion AM7778 
iBlot Gel Transfer Stack  Invitrogen IB301002 
GeneScreen Plus   PerkinElmer NEF1017001PK 
Yeast RNA    Thermo Scientific AM7118 
Denhardt’s Solution   Thermo Scientific 750018 
ATP, [g-P32]    PerkinElmer 
 
Buffers 
Lysis buffer (RIPA) -  50 mM Tris-HCl, pH 7.4 
   100 mM NaCl, 1% NP-40 
   0.1% SDS 
   0.5% sodium deoxycholate,  
   protease inhibitors (1:1000 add fresh each time) 
   RNAse Inhibitor (1:1000, add fresh each time) 
 
Proteinase K buffer -  100 mM Tris-HCl pH 7.4 
   50 mM NaCl 
   10 mM EDTA 
 
Proteinase K urea buffer- 100 mM Tris-HCl pH 7.4 
         50 mM NaCl  
         10 mM EDTA 
         7 M urea 
 
Hybridization buffer-  SSC    6mLs 
   10% SDS  2mLs 
   Denhardt Solution 800uls 
   Yeast RNA  400uls 
   Fill to 20mLs with ddH20 
 
Wash buffer-  SSC -   10mLs   
   10% SDS -    1mLs 
   Fill to 100mLs with ddH20 
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Stripping buffer-  SSC -   500uLs 
      10% SDS -      1mLs 
   Fill to 100mLs with ddH20 
 
Co-Immunoprecipitation 
1) Transfect HEK293 cells in 15 cm plates with plasmids. Transfect 2 plates per sample with 
PolyJet 
2) 24 hrs post transfection, remove media and wash with 10mLs of ice-cold PBS. Remove PBS 
3) Place dish on ice and irradiate with 150 mJ/cm2 at 254 nm using a stratalinker 
4) Use 2mLs RIPA buffer to collect cells by pipetting and transfer cells to microfuge tubes  
5) Pellet cells (spin at top speed for 10 sec at 4°C), then remove supernatant. Either snap-freeze 
cell pellets on dry ice and store at -80°C until use or continue working with pellet. 
6) To prepare beads, wash beads Protein G beads twice with RIPA buffer. Use 75uls of beads 
per sample. 
7) Re-suspend beads in 100uls of lysis buffer and add 10ug of antibody for beads and rotate 
tubes at room temperature for 60 mins. 
1) Anti GFP Antibody 
2) Anti cMyc Antibody 
3) NC mouse sera  
8) In the meantime, re-suspend cell pellet in 1mL lysis buffer without RNAse Inhibitor. Add 
10uls of 1:100 RNase I and 2 uls of Turbo DNase to the cell lysate and incubate for 3 min at 
37°C, shaking at 1,100 rpm, then immediately transfer to ice. 
9) Spin at 4°C at 14,000 rpm for 20 min and collect the cleared supernatant. 
10) Split the supernatant in half for each sample. Half for +Ab and half for -Ab control 
11) Remove lysis buffer from the beads, add cell lysate to beads and rotate for 2 hr at 4°C. 
12) Discard the supernatant and wash beads 2x with 750uls of RIPA buffer and then 2x with 
750uls Proteinase K buffer  
13) Re-suspend beads in 200uls of Proteinase K buffer and add 10uls of Proteinase K. Incubate 
for 30 mins at 37°C, shaking at 1,100 rpm. 
14) Add 130uls of Proteinase K Urea buffer and add 10uls of Proteinase K. Incubate for 30 mins 
at 37°C, shaking at 1,100 rpm. 
15) Add 400uls of RNA phenol/chloroform (pH 4.3) to tube and centrifuge at 14,000 rpm at 4°C 
to separate the phases.  
16) Transfer the aqueous layer to a new tube. Add 400uls of chloroform and centrifuge at 14,000 
rpm at 4°C. 
17) Transfer the aqueous layer into a new tube. Add 1mL of 100% ethanol, 0.5uls glycoblue and 
40uls 3M sodium acetate. Precipitate over night at -80°C. 
 
RNA Preparation and Northern Blot Analysis 
18) Centrifuge 10 mins, 14,000rpm at 4°C to obtain RNA pellet. Wash again with 70% EtOH. 
19) Air dry pellet on ice for 5 mins.  
20) Add 10uls of formamide dye and heat sample at 95°C for 10 mins. 
21) Immediately place RNA on ice to cool.  
22) Load samples on a 15% urea gel. For RNA ladder, prepare Decade Markers as per 
manufactures protocol 
23) Run gel at 100V in 4°C until bromophenol blue is at the bottom of the gel. 
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24) Label probe while running the gel (see blow). 
25) Transfer gel onto a membrane using iblot from Invitrogen. Transfer for 6 minutes. 
26) Crosslink RNA to membrane by setting Fotodyne DNA Transfer Lamp UV to 160 J/m2 for 
90 seconds. 
27) Place membrane between two Whatman Cellulose Filter Paper and dry membrane for 10mins 
at 80°C using the gel dryer. 
28) Place membrane into glass tube and add 20mLs hybridization buffer. Pre-hybridize 
membrane for 2 hours at 32°C by rotating end over end in hybridization oven.  
29) Heat probe to 90oC for four minutes. Add 4uls of labeled probe to the hybridization buffer. 
Hybridize g-P32 radiolabeled dT(40) overnight at 32°C. 
30) Dispose hybridization buffer in appropriate waste container.  
31) Wash membrane 3x by adding 20mls of wash buffer and rotating for 20 minutes.  
32) Wrap membrane with saran wrap, place phosphor screen, and expose overnight.  
33) Scan membrane using GE typhoon scanner.  
34) Strip membrane by adding 20mLs of stripping buffer and rotating at 70°C for 20 minutes. 
Strip 3x. 
35) Reprobe for pre-tRNA Met-e at 37°C. 
 
Labeling Probe 
1) Add following components: 
a. 25 uM probe  2 uls 
b. T4 PNK Buffer  2 uls  
c. dH20   14 uls 
d. g-P32 ATP*   1 ul  (activity of ~3000Ci/mmol)  
e. T4 enzyme  1 ul 
20 
*Adjust volume according to activity of g-P32 ATP 
 
2) Incubate at 37oC for 2 hours. 
3) Store in radioactive freezer. 
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Polysome Gradients 
Adapted from 231  
 
Reagents  
Sucrose    Fisher Scientific BP220-212 
Beckman Coulter Tubes  Beckman Coulter 331372  
PBS     MultiCell 311-010-C1 
Cycloheximide   Sigma-Aldrich C7698 
Protease inhibitor cocktail  Thermo Scientific 78425 
RNAse Inhibitor   Ambion AM2696 
Triton X-100    Sigma T8787-50mL 
Sodium Deoxycholate   Sigma-Aldrich D6750 
 
Buffers 
10x Sucrose Gradient Buffer-  200 mM HEPES (pH 7.6) 
     1 M KCl 
     50 mM MgCl2 
     100 µg/ml cycloheximide 
     1x protease inhibitor cocktail (EDTA-free) 
     100 units/ml RNase inhibitor 
 
Hypotonic Buffer-    5 mM Tris-HCl (pH 7.5) 
     2.5 mM MgCl2 
     1.5 mM KCl  
     1x protease inhibitor cocktail (EDTA-free) 
 
Gradient Preparation 
1) Prepare 50 ml of 60% sucrose solution in MilliQ water and 10ml of 10x sucrose gradient 
buffer. Filter solutions with 0.22 µm filter. 
2) Prepare 10-50% stock sucrose solutions using 60% sucrose.  
 Final (%) 60% Stock (mL) water (mL) 10X sucrose gradient 
 50  8.3   0.7  1 
 45  7.5   1.5  1 
 40  6.7   2.3  1 
 35  5.8   3.2  1 
 30  5.0   4.0  1 
 25  4.2   4.8  1 
 20  3.3   5.7  1 
 15  2.5   6.5  1 
 10  1.7   7.3  1 
3) Add 1.2 mL of the 50% sucrose solution to a Beckman tube. Flash freeze the gradient in 
liquid nitrogen or place in -80°C for one hour. Add 1.2mL of the 45% sucrose solution and 
repeat flash freeze. Continue with each layer until each layer has been flash frozen. 
4) Cover tube with parafilm and store at -80°C until use. 
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RNA Preparation 
1) Seed cells into 3 15-cm Petri dishes at 50-60% confluency 18-24 hours prior to transfection. 
2) Transfect cells with 12ug DNA. 
3) Lyse 24 hours post transfection. Before lysing, incubate cells with cycloheximide at a final 
concentration of 100 µg/ml for 5 min at 37 °C and 5% CO2. 
4) Wash cells twice with 10 ml of ice-cold 1x PBS containing 100 µg/ml cycloheximide. 
5) Scrape cells in 5 ml of ice-cold 1x PBS containing 100 µg/ml cycloheximide and collect in a 
50 ml tube. 
6) Collect cells by centrifugation at 1200rpm for 5 min at 4°C. 
7) Discard supernatant and re-suspend cells in 425 µl of hypotonic buffer . 
8) Add 5 µl of 10 mg/ml cyclohexamide, 1 µl of 1M DTT, 100 units of RNAse inhibitor and 
vortex for 5 secs.  
9) Add of 25 µl of 10% Triton X-100 (final concentration 0.5%) and 25 µl of 10% sodium 
deoxycholate (final concentration 0.5%) and vortex for 5 secs. 
10) Centrifuge lysates at 14,000 rpm for 15 mins at 4°C and transfer supernatant to a new pre-
chilled 1.5 ml tube.  
11) Measure OD at 260 nm for each sample using a spectrophotometer. 
12) Immediately load RNA onto gradients. 
 
Polysome Fractionation 
1) Transfer ultracentrifuge tubes containing sucrose gradients into pre-chilled rotor buckets. 
2) Load equal OD 260nm of lysates (10-20 OD). Adjust lysates so that they contain the same 
OD in 500 µl of lysis buffer and load onto each sucrose gradient. 
3) Weigh and balance each gradient before the ultra-centrifugation. 
4) Centrifuge at 30,000 rpm, for 4 hr at 4 °C using SW41Ti rotor.  
5) When 30 minutes of spin are left, switch on UV lamp. 
6) Switch on pump and fraction collector. Fill the tubing with the chasing solution (60% (w/v) 
sucrose containing 0.02% (w/v) bromophenol blue) until it reaches the needle. Make sure to 
see at least one drop coming out of the needle, and ascertain that no bubbles are introduced in 
the pump syringe or tubing. 
7) Place the gradient and pierce the tube with the needle by twisting the knob below the tube 
holder. 
8) Set the pump at 1.5 ml/min and collect the fractions. Collect 20 drops per fraction. (~ 500 µl 
in each fraction for 18 fractions). 
9) Stop collecting as soon as the first drop of chasing solution falls in a 2 ml collecting tube. 
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Immunofluorescence 
Reagents 
PBS    MultiCell 311-010-C1 
Paraformaldehyde  Sigma-Aldrich P6148-500G 
Triton X-100   Sigma T8787-50mL 
DAPI    Vector H-1200 
 
1) Grow cells on slide. 
1) Wash cells 2X with cold PBS. 
2) Fix cells with 4% paraformaldehyde in PBS for 10 min at RT. 
3) Wash cells 2X with PBS. 
4) Permeabilize cells with 0.3% Triton-X in PBS. 
5) Block cells with 2% BSA and 0.02% sodium azide in PBS at room temperature for 1 hour. 
6) Incubate cells with primary antibody (1:100 – 1:500) at 4°C overnight. 
7) Wash cells 3X with PBS. 
8) Incubate cells with appropriate TRITC/FITC-conjugated secondary antibody (1:500) for 1 
hour at room temperature. 
9) Wash cells 3X with PBS. 
10) Add one drop of DAPI mounting media and place coverslip on slide. 
11) Allow 1 hour at room temperature of DAPI media to dry.  
12) Observe slide using Zeiss LSM 700 or store slides in dark at 4oC. 
 
 
 
 
 
 
 
 
 
